BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51259045 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN(C)C)c2ccccc12 |r,wD:6.9,3.2,(22.93,-34.28,;22.12,-32.96,;22.85,-31.6,;20.58,-33,;19.77,-31.7,;18.22,-31.74,;17.5,-33.09,;18.31,-34.41,;19.85,-34.36,;15.96,-33.15,;15.23,-34.51,;13.7,-34.56,;12.88,-33.25,;13.6,-31.89,;15.15,-31.84,;11.35,-33.31,;10.4,-32.09,;8.95,-32.62,;7.68,-31.76,;7.78,-30.23,;6.51,-29.38,;9.16,-29.56,;9.01,-34.16,;7.91,-35.23,;8.28,-36.72,;9.76,-37.13,;10.86,-36.06,;10.49,-34.59,)| InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-15-13-23(14-16-27)28-18-21(17-26(3)4)24-7-5-6-8-25(24)28/h5-8,18-20,22-23H,9-17H2,1-4H3 WVGUPYZLPGESLO-UHFFFAOYSA-N 50514538 CHEMBL4457077 Nociceptin receptor Homo sapiens 44 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514538&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563691 440723120 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259046 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(52.76,-21.76,;51.95,-20.45,;52.68,-19.09,;50.41,-20.49,;49.6,-19.19,;48.05,-19.23,;47.33,-20.58,;48.14,-21.89,;49.67,-21.85,;45.79,-20.64,;45.06,-21.99,;43.53,-22.04,;42.71,-20.74,;43.43,-19.38,;44.98,-19.33,;41.17,-20.79,;40.23,-19.58,;38.78,-20.1,;37.51,-19.25,;36.13,-19.92,;34.86,-19.07,;33.48,-19.74,;34.96,-17.54,;38.84,-21.64,;37.73,-22.71,;38.11,-24.2,;39.59,-24.62,;40.69,-23.55,;40.32,-22.07,)| InChI=1S/C24H36N4S/c1-17(2)18-7-9-20(10-8-18)27-13-11-21(12-14-27)28-16-19(15-26-24(25)29)22-5-3-4-6-23(22)28/h3-6,16-18,20-21H,7-15H2,1-2H3,(H3,25,26,29) BTZMBSYIWRQRBI-UHFFFAOYSA-N 50514539 CHEMBL4460695 Nociceptin receptor Homo sapiens 11 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514539&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563466 440723121 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259047 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CO)c2ccccc12 |r,wD:6.9,3.2,(63.96,-12.85,;63.15,-11.53,;63.89,-10.17,;61.61,-11.57,;60.8,-10.27,;59.26,-10.31,;58.53,-11.66,;59.34,-12.98,;60.88,-12.93,;56.99,-11.72,;56.27,-13.07,;54.73,-13.13,;53.91,-11.82,;54.63,-10.46,;56.18,-10.41,;52.38,-11.88,;51.43,-10.66,;49.98,-11.19,;48.71,-10.33,;48.82,-8.8,;50.04,-12.73,;48.94,-13.79,;49.31,-15.29,;50.79,-15.7,;51.89,-14.63,;51.52,-13.16,)| InChI=1S/C23H34N2O/c1-17(2)18-7-9-20(10-8-18)24-13-11-21(12-14-24)25-15-19(16-26)22-5-3-4-6-23(22)25/h3-6,15,17-18,20-21,26H,7-14,16H2,1-2H3 JDXUKGDQAXGTDS-UHFFFAOYSA-N 50514540 CHEMBL4439997 Mu-type opioid receptor Homo sapiens 716 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514540&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563650 440723122 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259048 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC[C@@H](O)C2)c2ccccc12 |r,wD:6.9,3.2,22.24,(23.74,-8.52,;22.92,-7.21,;23.66,-5.85,;21.38,-7.25,;20.57,-5.95,;19.03,-5.99,;18.3,-7.34,;19.12,-8.66,;20.65,-8.61,;16.76,-7.4,;16.04,-8.75,;14.5,-8.81,;13.68,-7.5,;14.4,-6.14,;15.95,-6.09,;12.15,-7.56,;11.2,-6.34,;9.75,-6.87,;8.48,-6.01,;7.1,-6.68,;5.74,-5.97,;4.64,-7.04,;5.31,-8.41,;4.59,-9.77,;6.83,-8.2,;9.81,-8.41,;8.71,-9.47,;9.08,-10.97,;10.56,-11.38,;11.66,-10.31,;11.29,-8.84,)| InChI=1S/C27H41N3O/c1-20(2)21-7-9-23(10-8-21)29-15-11-24(12-16-29)30-18-22(17-28-14-13-25(31)19-28)26-5-3-4-6-27(26)30/h3-6,18,20-21,23-25,31H,7-17,19H2,1-2H3 UVJCSVMAXSVVJZ-UHFFFAOYSA-N 50514541 CHEMBL4473045 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514541&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578456 440723123 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259049 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(C(N)=O)c2ccccc12 |r,wD:6.9,3.2,(24.31,-8.5,;23.5,-7.18,;24.23,-5.83,;21.96,-7.23,;21.15,-5.92,;19.6,-5.96,;18.88,-7.32,;19.69,-8.63,;21.22,-8.59,;17.34,-7.38,;16.61,-8.73,;15.08,-8.78,;14.26,-7.48,;14.98,-6.11,;16.53,-6.06,;12.72,-7.53,;11.78,-6.31,;10.33,-6.84,;9.06,-5.98,;7.68,-6.66,;9.16,-4.45,;10.39,-8.38,;9.29,-9.45,;9.66,-10.94,;11.14,-11.36,;12.24,-10.29,;11.87,-8.81,)| InChI=1S/C23H33N3O/c1-16(2)17-7-9-18(10-8-17)25-13-11-19(12-14-25)26-15-21(23(24)27)20-5-3-4-6-22(20)26/h3-6,15-19H,7-14H2,1-2H3,(H2,24,27) OLKROLWNEXOWRE-UHFFFAOYSA-N 50514542 CHEMBL4473383 Delta-type opioid receptor Homo sapiens 2712 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514542&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563695 440723124 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259050 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(N)CC2)c2ccccc12 |r,wD:6.9,3.2,(50.68,-46.35,;49.87,-45.03,;50.61,-43.68,;48.33,-45.08,;47.52,-43.77,;45.97,-43.81,;45.24,-45.17,;46.06,-46.48,;47.59,-46.44,;43.7,-45.23,;42.98,-46.58,;41.44,-46.63,;40.62,-45.33,;41.34,-43.96,;42.89,-43.91,;39.09,-45.38,;38.14,-44.16,;36.69,-44.69,;35.42,-43.83,;34.04,-44.51,;32.77,-43.65,;31.4,-44.32,;31.28,-45.85,;29.9,-46.52,;32.56,-46.71,;33.94,-46.04,;36.75,-46.23,;35.65,-47.3,;36.02,-48.79,;37.5,-49.21,;38.6,-48.14,;38.23,-46.66,)| InChI=1S/C28H44N4/c1-21(2)22-7-9-25(10-8-22)31-17-13-26(14-18-31)32-20-23(27-5-3-4-6-28(27)32)19-30-15-11-24(29)12-16-30/h3-6,20-22,24-26H,7-19,29H2,1-2H3 QGUZGYQHAUOCCK-UHFFFAOYSA-N 50514543 CHEMBL4590786 Kappa-type opioid receptor Homo sapiens 3456 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514543&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563500 440723125 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259051 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNCCO)c2ccccc12 |r,wD:6.9,3.2,(27.23,-22.87,;26.41,-21.55,;27.15,-20.19,;24.87,-21.59,;24.06,-20.29,;22.52,-20.33,;21.79,-21.68,;22.61,-23,;24.14,-22.95,;20.25,-21.74,;19.53,-23.1,;17.99,-23.15,;17.17,-21.84,;17.9,-20.48,;19.44,-20.43,;15.64,-21.9,;14.69,-20.68,;13.25,-21.21,;11.97,-20.35,;10.59,-21.03,;9.32,-20.17,;7.94,-20.84,;6.67,-19.99,;13.3,-22.75,;12.2,-23.82,;12.57,-25.31,;14.06,-25.72,;15.16,-24.65,;14.78,-23.18,)| InChI=1S/C25H39N3O/c1-19(2)20-7-9-22(10-8-20)27-14-11-23(12-15-27)28-18-21(17-26-13-16-29)24-5-3-4-6-25(24)28/h3-6,18-20,22-23,26,29H,7-17H2,1-2H3 MWMHYNCBTDRUCG-UHFFFAOYSA-N 50514544 CHEMBL4518220 Mu-type opioid receptor Homo sapiens 973 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514544&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578518 440723126 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259052 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1ccc2ccccc12 |r,wD:6.9,3.2,(20.66,-19.76,;21.96,-18.93,;23.33,-19.65,;21.9,-17.39,;23.2,-16.56,;23.13,-15.02,;21.77,-14.31,;20.47,-15.14,;20.53,-16.67,;21.69,-12.77,;20.33,-12.06,;20.26,-10.53,;21.56,-9.69,;22.93,-10.4,;23,-11.94,;21.48,-8.16,;22.69,-7.2,;22.14,-5.76,;20.61,-5.84,;19.52,-4.75,;18.04,-5.14,;17.64,-6.63,;18.72,-7.71,;20.19,-7.32,)| InChI=1S/C22H32N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,11,16-18,20-21H,7-10,12-15H2,1-2H3 RUVSOGDMGUPNJT-UHFFFAOYSA-N 50514545 CHEMBL4435280 Delta-type opioid receptor Homo sapiens 923 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514545&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188443 440723127 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259053 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)CCCCCN)c2ccccc12 |r,wD:6.9,3.2,(30.71,-51.51,;29.9,-50.19,;30.64,-48.83,;28.36,-50.23,;27.55,-48.92,;26,-48.97,;25.27,-50.32,;26.09,-51.64,;27.62,-51.59,;23.73,-50.38,;23,-51.74,;21.47,-51.79,;20.64,-50.48,;21.37,-49.12,;22.92,-49.07,;19.11,-50.54,;18.16,-49.32,;16.71,-49.84,;15.44,-48.99,;14.06,-49.66,;12.78,-48.81,;12.89,-47.27,;11.4,-49.48,;10.13,-48.62,;8.75,-49.3,;7.47,-48.44,;6.09,-49.12,;4.82,-48.26,;16.77,-51.39,;15.66,-52.46,;16.04,-53.95,;17.52,-54.37,;18.62,-53.29,;18.25,-51.82,)| InChI=1S/C29H46N4O/c1-22(2)23-11-13-25(14-12-23)32-18-15-26(16-19-32)33-21-24(27-8-5-6-9-28(27)33)20-31-29(34)10-4-3-7-17-30/h5-6,8-9,21-23,25-26H,3-4,7,10-20,30H2,1-2H3,(H,31,34) ZUGCJUUUBNUVGL-UHFFFAOYSA-N 50514546 CHEMBL4521436 Kappa-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514546&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155542684 440723128 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259054 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCN)c2ccccc12 InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-16-13-23(14-17-27)28-18-21(6-5-15-26)24-7-3-4-8-25(24)28/h3-4,7-8,18-20,22-23H,5-6,9-17,26H2,1-2H3 SJRTYDYZXKADCH-UHFFFAOYSA-N 50514547 CHEMBL4451073 Nociceptin receptor Homo sapiens 249 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514547&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563704 440723129 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259055 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(52.76,-21.76,;51.95,-20.45,;52.68,-19.09,;50.41,-20.49,;49.6,-19.19,;48.05,-19.23,;47.33,-20.58,;48.14,-21.89,;49.67,-21.85,;45.79,-20.64,;45.06,-21.99,;43.53,-22.04,;42.71,-20.74,;43.43,-19.38,;44.98,-19.33,;41.17,-20.79,;40.23,-19.58,;38.78,-20.1,;37.51,-19.25,;36.13,-19.92,;34.86,-19.07,;33.48,-19.74,;34.96,-17.54,;38.84,-21.64,;37.73,-22.71,;38.11,-24.2,;39.59,-24.62,;40.69,-23.55,;40.32,-22.07,)| InChI=1S/C24H36N4S/c1-17(2)18-7-9-20(10-8-18)27-13-11-21(12-14-27)28-16-19(15-26-24(25)29)22-5-3-4-6-23(22)28/h3-6,16-18,20-21H,7-15H2,1-2H3,(H3,25,26,29) BTZMBSYIWRQRBI-UHFFFAOYSA-N 50514539 CHEMBL4460695 Nociceptin receptor Homo sapiens 343 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514539&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563466 440723121 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259056 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1ccc2ccccc12 |r,wD:6.9,3.2,(20.66,-19.76,;21.96,-18.93,;23.33,-19.65,;21.9,-17.39,;23.2,-16.56,;23.13,-15.02,;21.77,-14.31,;20.47,-15.14,;20.53,-16.67,;21.69,-12.77,;20.33,-12.06,;20.26,-10.53,;21.56,-9.69,;22.93,-10.4,;23,-11.94,;21.48,-8.16,;22.69,-7.2,;22.14,-5.76,;20.61,-5.84,;19.52,-4.75,;18.04,-5.14,;17.64,-6.63,;18.72,-7.71,;20.19,-7.32,)| InChI=1S/C22H32N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,11,16-18,20-21H,7-10,12-15H2,1-2H3 RUVSOGDMGUPNJT-UHFFFAOYSA-N 50514545 CHEMBL4435280 Mu-type opioid receptor Homo sapiens 232 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514545&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188443 440723127 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259057 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)N1CCc2ccccc12 |r,wD:6.9,3.2,(8.81,-19.41,;10.12,-18.58,;11.48,-19.3,;10.05,-17.04,;11.35,-16.22,;11.29,-14.67,;9.93,-13.96,;8.62,-14.79,;8.69,-16.32,;9.85,-12.42,;8.49,-11.71,;8.42,-10.18,;9.71,-9.35,;11.08,-10.05,;11.15,-11.6,;9.64,-7.81,;10.84,-6.85,;10.3,-5.41,;8.76,-5.49,;7.68,-4.4,;6.19,-4.79,;5.79,-6.28,;6.88,-7.36,;8.35,-6.97,)| InChI=1S/C22H34N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,17-18,20-21H,7-16H2,1-2H3 FALYKCYWERAVPH-UHFFFAOYSA-N 50514548 CHEMBL4570328 Nociceptin receptor Homo sapiens 10 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514548&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188459 440723130 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259058 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1ccc2ccccc12 |r,wD:6.9,3.2,(20.66,-19.76,;21.96,-18.93,;23.33,-19.65,;21.9,-17.39,;23.2,-16.56,;23.13,-15.02,;21.77,-14.31,;20.47,-15.14,;20.53,-16.67,;21.69,-12.77,;20.33,-12.06,;20.26,-10.53,;21.56,-9.69,;22.93,-10.4,;23,-11.94,;21.48,-8.16,;22.69,-7.2,;22.14,-5.76,;20.61,-5.84,;19.52,-4.75,;18.04,-5.14,;17.64,-6.63,;18.72,-7.71,;20.19,-7.32,)| InChI=1S/C22H32N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,11,16-18,20-21H,7-10,12-15H2,1-2H3 RUVSOGDMGUPNJT-UHFFFAOYSA-N 50514545 CHEMBL4435280 Nociceptin receptor Homo sapiens 9.8 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514545&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188443 440723127 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259059 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN)c2ccccc12 |r,wD:6.9,3.2,(34,-19.87,;35.3,-19.05,;36.67,-19.77,;35.24,-17.51,;36.54,-16.68,;36.48,-15.14,;35.12,-14.43,;33.81,-15.26,;33.88,-16.79,;35.04,-12.89,;33.68,-12.18,;33.61,-10.65,;34.9,-9.81,;36.27,-10.52,;36.34,-12.06,;34.83,-8.28,;36.03,-7.32,;35.49,-5.88,;36.33,-4.59,;37.86,-4.68,;33.95,-5.95,;32.87,-4.86,;31.38,-5.25,;30.98,-6.74,;32.07,-7.83,;33.54,-7.44,)| InChI=1S/C23H35N3/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24)22-5-3-4-6-23(22)26/h3-6,16-18,20-21H,7-15,24H2,1-2H3 IPYIZXVSNKMLOX-UHFFFAOYSA-N 50514549 CHEMBL4548515 Nociceptin receptor Homo sapiens 0.300000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514549&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563655 440723131 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259060 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCN)c2ccccc12 InChI=1S/C24H37N3/c1-18(2)19-7-9-21(10-8-19)26-15-12-22(13-16-26)27-17-20(11-14-25)23-5-3-4-6-24(23)27/h3-6,17-19,21-22H,7-16,25H2,1-2H3 OPIHQPUQFVMQAI-UHFFFAOYSA-N 50514550 CHEMBL4465668 Nociceptin receptor Homo sapiens 2.3 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514550&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188462 440723132 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259061 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCN)c2ccccc12 InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-16-13-23(14-17-27)28-18-21(6-5-15-26)24-7-3-4-8-25(24)28/h3-4,7-8,18-20,22-23H,5-6,9-17,26H2,1-2H3 SJRTYDYZXKADCH-UHFFFAOYSA-N 50514547 CHEMBL4451073 Nociceptin receptor Homo sapiens 21 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514547&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563704 440723129 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259062 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(O)CC2)c2ccccc12 |r,wD:6.9,3.2,(75.58,-45.79,;74.76,-44.48,;75.5,-43.12,;73.22,-44.52,;72.41,-43.21,;70.87,-43.26,;70.14,-44.61,;70.95,-45.93,;72.49,-45.88,;68.6,-44.67,;67.87,-46.02,;66.34,-46.07,;65.52,-44.77,;66.24,-43.41,;67.79,-43.36,;63.98,-44.82,;63.04,-43.61,;61.59,-44.13,;60.32,-43.28,;58.94,-43.95,;57.67,-43.09,;56.29,-43.76,;56.18,-45.29,;54.8,-45.96,;57.45,-46.15,;58.84,-45.48,;61.65,-45.67,;60.54,-46.74,;60.91,-48.24,;62.4,-48.65,;63.5,-47.58,;63.13,-46.1,)| InChI=1S/C28H43N3O/c1-21(2)22-7-9-24(10-8-22)30-17-11-25(12-18-30)31-20-23(27-5-3-4-6-28(27)31)19-29-15-13-26(32)14-16-29/h3-6,20-22,24-26,32H,7-19H2,1-2H3 PCXCVPKTSPZHJW-UHFFFAOYSA-N 50514551 CHEMBL4550088 Nociceptin receptor Homo sapiens 64 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514551&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578506 440723133 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259063 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC[C@@H](O)C2)c2ccccc12 |r,wD:6.9,3.2,22.24,(23.74,-8.52,;22.92,-7.21,;23.66,-5.85,;21.38,-7.25,;20.57,-5.95,;19.03,-5.99,;18.3,-7.34,;19.12,-8.66,;20.65,-8.61,;16.76,-7.4,;16.04,-8.75,;14.5,-8.81,;13.68,-7.5,;14.4,-6.14,;15.95,-6.09,;12.15,-7.56,;11.2,-6.34,;9.75,-6.87,;8.48,-6.01,;7.1,-6.68,;5.74,-5.97,;4.64,-7.04,;5.31,-8.41,;4.59,-9.77,;6.83,-8.2,;9.81,-8.41,;8.71,-9.47,;9.08,-10.97,;10.56,-11.38,;11.66,-10.31,;11.29,-8.84,)| InChI=1S/C27H41N3O/c1-20(2)21-7-9-23(10-8-21)29-15-11-24(12-16-29)30-18-22(17-28-14-13-25(31)19-28)26-5-3-4-6-27(26)30/h3-6,18,20-21,23-25,31H,7-17,19H2,1-2H3 UVJCSVMAXSVVJZ-UHFFFAOYSA-N 50514541 CHEMBL4473045 Nociceptin receptor Homo sapiens 9.5 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514541&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578456 440723123 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259064 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNCCO)c2ccccc12 |r,wD:6.9,3.2,(27.23,-22.87,;26.41,-21.55,;27.15,-20.19,;24.87,-21.59,;24.06,-20.29,;22.52,-20.33,;21.79,-21.68,;22.61,-23,;24.14,-22.95,;20.25,-21.74,;19.53,-23.1,;17.99,-23.15,;17.17,-21.84,;17.9,-20.48,;19.44,-20.43,;15.64,-21.9,;14.69,-20.68,;13.25,-21.21,;11.97,-20.35,;10.59,-21.03,;9.32,-20.17,;7.94,-20.84,;6.67,-19.99,;13.3,-22.75,;12.2,-23.82,;12.57,-25.31,;14.06,-25.72,;15.16,-24.65,;14.78,-23.18,)| InChI=1S/C25H39N3O/c1-19(2)20-7-9-22(10-8-20)27-14-11-23(12-15-27)28-18-21(17-26-13-16-29)24-5-3-4-6-25(24)28/h3-6,18-20,22-23,26,29H,7-17H2,1-2H3 MWMHYNCBTDRUCG-UHFFFAOYSA-N 50514544 CHEMBL4518220 Nociceptin receptor Homo sapiens 136 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514544&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578518 440723126 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259065 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)[C@@H](N)CCCNC(N)=N)c2ccccc12 |r,wU:22.24,wD:6.9,3.2,(63.55,-38.33,;62.74,-37.01,;63.48,-35.65,;61.19,-37.05,;60.38,-35.75,;58.84,-35.79,;58.11,-37.14,;58.92,-38.46,;60.46,-38.41,;56.57,-37.2,;55.84,-38.56,;54.3,-38.61,;53.48,-37.3,;54.2,-35.94,;55.75,-35.89,;51.94,-37.36,;51,-36.14,;49.55,-36.67,;48.27,-35.81,;46.89,-36.48,;45.62,-35.63,;45.72,-34.09,;44.24,-36.3,;44.13,-37.84,;42.96,-35.45,;41.58,-36.12,;40.3,-35.26,;38.92,-35.94,;37.65,-35.08,;36.27,-35.76,;37.75,-33.55,;49.61,-38.21,;48.5,-39.28,;48.87,-40.77,;50.36,-41.19,;51.46,-40.12,;51.09,-38.64,)| InChI=1S/C29H47N7O/c1-20(2)21-9-11-23(12-10-21)35-16-13-24(14-17-35)36-19-22(25-6-3-4-8-27(25)36)18-34-28(37)26(30)7-5-15-33-29(31)32/h3-4,6,8,19-21,23-24,26H,5,7,9-18,30H2,1-2H3,(H,34,37)(H4,31,32,33) WLQVWCBBPYAMOQ-UHFFFAOYSA-N 50514552 CHEMBL4594096 Nociceptin receptor Homo sapiens 11 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514552&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 155569552 440723134 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259066 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)CCCCCN)c2ccccc12 |r,wD:6.9,3.2,(30.71,-51.51,;29.9,-50.19,;30.64,-48.83,;28.36,-50.23,;27.55,-48.92,;26,-48.97,;25.27,-50.32,;26.09,-51.64,;27.62,-51.59,;23.73,-50.38,;23,-51.74,;21.47,-51.79,;20.64,-50.48,;21.37,-49.12,;22.92,-49.07,;19.11,-50.54,;18.16,-49.32,;16.71,-49.84,;15.44,-48.99,;14.06,-49.66,;12.78,-48.81,;12.89,-47.27,;11.4,-49.48,;10.13,-48.62,;8.75,-49.3,;7.47,-48.44,;6.09,-49.12,;4.82,-48.26,;16.77,-51.39,;15.66,-52.46,;16.04,-53.95,;17.52,-54.37,;18.62,-53.29,;18.25,-51.82,)| InChI=1S/C29H46N4O/c1-22(2)23-11-13-25(14-12-23)32-18-15-26(16-19-32)33-21-24(27-8-5-6-9-28(27)33)20-31-29(34)10-4-3-7-17-30/h5-6,8-9,21-23,25-26H,3-4,7,10-20,30H2,1-2H3,(H,31,34) ZUGCJUUUBNUVGL-UHFFFAOYSA-N 50514546 CHEMBL4521436 Nociceptin receptor Homo sapiens 23 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514546&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 155542684 440723128 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259067 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(C(N)=O)c2ccccc12 |r,wD:6.9,3.2,(24.31,-8.5,;23.5,-7.18,;24.23,-5.83,;21.96,-7.23,;21.15,-5.92,;19.6,-5.96,;18.88,-7.32,;19.69,-8.63,;21.22,-8.59,;17.34,-7.38,;16.61,-8.73,;15.08,-8.78,;14.26,-7.48,;14.98,-6.11,;16.53,-6.06,;12.72,-7.53,;11.78,-6.31,;10.33,-6.84,;9.06,-5.98,;7.68,-6.66,;9.16,-4.45,;10.39,-8.38,;9.29,-9.45,;9.66,-10.94,;11.14,-11.36,;12.24,-10.29,;11.87,-8.81,)| InChI=1S/C23H33N3O/c1-16(2)17-7-9-18(10-8-17)25-13-11-19(12-14-25)26-15-21(23(24)27)20-5-3-4-6-22(20)26/h3-6,15-19H,7-14H2,1-2H3,(H2,24,27) OLKROLWNEXOWRE-UHFFFAOYSA-N 50514542 CHEMBL4473383 Nociceptin receptor Homo sapiens 129 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514542&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563695 440723124 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259068 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(\C=N\O)c2ccccc12 |r,wD:6.9,3.2,(48.18,-8.94,;47.37,-7.63,;48.1,-6.27,;45.82,-7.67,;45.02,-6.36,;43.47,-6.41,;42.74,-7.76,;43.56,-9.07,;45.09,-9.03,;41.21,-7.82,;40.48,-9.17,;38.95,-9.22,;38.13,-7.92,;38.85,-6.55,;40.39,-6.51,;36.59,-7.97,;35.65,-6.76,;34.2,-7.28,;32.93,-6.43,;32.98,-4.9,;31.76,-4.04,;34.26,-8.82,;33.15,-9.89,;33.52,-11.38,;35.01,-11.8,;36.11,-10.73,;35.74,-9.25,)| InChI=1S/C23H33N3O/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24-27)22-5-3-4-6-23(22)26/h3-6,15-18,20-21,27H,7-14H2,1-2H3 KXDZSADJKWDKCN-UHFFFAOYSA-N 50514553 CHEMBL4439811 Nociceptin receptor Homo sapiens 2.2 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514553&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188454 440723135 C02658 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259069 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)N1CCc2ccccc12 |r,wD:6.9,3.2,(8.81,-19.41,;10.12,-18.58,;11.48,-19.3,;10.05,-17.04,;11.35,-16.22,;11.29,-14.67,;9.93,-13.96,;8.62,-14.79,;8.69,-16.32,;9.85,-12.42,;8.49,-11.71,;8.42,-10.18,;9.71,-9.35,;11.08,-10.05,;11.15,-11.6,;9.64,-7.81,;10.84,-6.85,;10.3,-5.41,;8.76,-5.49,;7.68,-4.4,;6.19,-4.79,;5.79,-6.28,;6.88,-7.36,;8.35,-6.97,)| InChI=1S/C22H34N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,17-18,20-21H,7-16H2,1-2H3 FALYKCYWERAVPH-UHFFFAOYSA-N 50514548 CHEMBL4570328 Mu-type opioid receptor Homo sapiens 604 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514548&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188459 440723130 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259070 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCN)c2ccccc12 InChI=1S/C24H37N3/c1-18(2)19-7-9-21(10-8-19)26-15-12-22(13-16-26)27-17-20(11-14-25)23-5-3-4-6-24(23)27/h3-6,17-19,21-22H,7-16,25H2,1-2H3 OPIHQPUQFVMQAI-UHFFFAOYSA-N 50514550 CHEMBL4465668 Mu-type opioid receptor Homo sapiens 437 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514550&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188462 440723132 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259071 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCN)c2ccccc12 InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-16-13-23(14-17-27)28-18-21(6-5-15-26)24-7-3-4-8-25(24)28/h3-4,7-8,18-20,22-23H,5-6,9-17,26H2,1-2H3 SJRTYDYZXKADCH-UHFFFAOYSA-N 50514547 CHEMBL4451073 Mu-type opioid receptor Homo sapiens 46 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514547&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563704 440723129 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259072 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(N)CC2)c2ccccc12 |r,wD:6.9,3.2,(50.68,-46.35,;49.87,-45.03,;50.61,-43.68,;48.33,-45.08,;47.52,-43.77,;45.97,-43.81,;45.24,-45.17,;46.06,-46.48,;47.59,-46.44,;43.7,-45.23,;42.98,-46.58,;41.44,-46.63,;40.62,-45.33,;41.34,-43.96,;42.89,-43.91,;39.09,-45.38,;38.14,-44.16,;36.69,-44.69,;35.42,-43.83,;34.04,-44.51,;32.77,-43.65,;31.4,-44.32,;31.28,-45.85,;29.9,-46.52,;32.56,-46.71,;33.94,-46.04,;36.75,-46.23,;35.65,-47.3,;36.02,-48.79,;37.5,-49.21,;38.6,-48.14,;38.23,-46.66,)| InChI=1S/C28H44N4/c1-21(2)22-7-9-25(10-8-22)31-17-13-26(14-18-31)32-20-23(27-5-3-4-6-28(27)32)19-30-15-11-24(29)12-16-30/h3-6,20-22,24-26H,7-19,29H2,1-2H3 QGUZGYQHAUOCCK-UHFFFAOYSA-N 50514543 CHEMBL4590786 Mu-type opioid receptor Homo sapiens 1308 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514543&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563500 440723125 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259073 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(O)CC2)c2ccccc12 |r,wD:6.9,3.2,(75.58,-45.79,;74.76,-44.48,;75.5,-43.12,;73.22,-44.52,;72.41,-43.21,;70.87,-43.26,;70.14,-44.61,;70.95,-45.93,;72.49,-45.88,;68.6,-44.67,;67.87,-46.02,;66.34,-46.07,;65.52,-44.77,;66.24,-43.41,;67.79,-43.36,;63.98,-44.82,;63.04,-43.61,;61.59,-44.13,;60.32,-43.28,;58.94,-43.95,;57.67,-43.09,;56.29,-43.76,;56.18,-45.29,;54.8,-45.96,;57.45,-46.15,;58.84,-45.48,;61.65,-45.67,;60.54,-46.74,;60.91,-48.24,;62.4,-48.65,;63.5,-47.58,;63.13,-46.1,)| InChI=1S/C28H43N3O/c1-21(2)22-7-9-24(10-8-22)30-17-11-25(12-18-30)31-20-23(27-5-3-4-6-28(27)31)19-29-15-13-26(32)14-16-29/h3-6,20-22,24-26,32H,7-19H2,1-2H3 PCXCVPKTSPZHJW-UHFFFAOYSA-N 50514551 CHEMBL4550088 Mu-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514551&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578506 440723133 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259074 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC(O)C2)c2ccccc12 |r,wD:6.9,3.2,(51.84,-7.48,;51.03,-6.16,;51.76,-4.81,;49.48,-6.21,;48.68,-4.9,;47.13,-4.94,;46.4,-6.3,;47.22,-7.61,;48.75,-7.57,;44.87,-6.36,;44.14,-7.71,;42.6,-7.76,;41.78,-6.46,;42.51,-5.09,;44.05,-5.04,;40.25,-6.51,;39.3,-5.29,;37.86,-5.82,;36.58,-4.96,;35.2,-5.64,;33.75,-5.14,;33.25,-6.59,;31.87,-7.26,;34.7,-7.09,;37.92,-7.36,;36.81,-8.43,;37.18,-9.92,;38.67,-10.34,;39.77,-9.27,;39.39,-7.79,)| InChI=1S/C26H39N3O/c1-19(2)20-7-9-22(10-8-20)28-13-11-23(12-14-28)29-16-21(15-27-17-24(30)18-27)25-5-3-4-6-26(25)29/h3-6,16,19-20,22-24,30H,7-15,17-18H2,1-2H3 LCHNDEARQJNFQA-UHFFFAOYSA-N 50514554 CHEMBL4556227 Mu-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514554&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563496 440723136 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259075 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(77.5,-21.25,;76.69,-19.93,;77.42,-18.58,;75.15,-19.98,;74.34,-18.67,;72.79,-18.71,;72.06,-20.07,;72.88,-21.38,;74.41,-21.34,;70.53,-20.13,;69.8,-21.48,;68.27,-21.53,;67.45,-20.23,;68.17,-18.86,;69.71,-18.81,;65.91,-20.28,;64.97,-19.06,;63.52,-19.59,;62.24,-18.73,;60.87,-19.41,;59.59,-18.55,;58.21,-19.23,;56.94,-18.37,;58.11,-20.76,;63.58,-21.13,;62.47,-22.2,;62.84,-23.69,;64.33,-24.11,;65.43,-23.04,;65.06,-21.56,)| InChI=1S/C25H38N4S/c1-18(2)19-7-9-21(10-8-19)28-15-12-22(13-16-28)29-17-20(11-14-27-25(26)30)23-5-3-4-6-24(23)29/h3-6,17-19,21-22H,7-16H2,1-2H3,(H3,26,27,30) SDNMVMVANFPUFO-UHFFFAOYSA-N 50514555 CHEMBL4467156 Mu-type opioid receptor Homo sapiens 227 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514555&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563698 440723137 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259076 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(27.01,-36.98,;26.19,-35.66,;26.93,-34.3,;24.65,-35.71,;23.85,-34.4,;22.3,-34.44,;21.57,-35.79,;22.39,-37.11,;23.92,-37.06,;20.03,-35.85,;19.31,-37.21,;17.77,-37.26,;16.95,-35.95,;17.67,-34.59,;19.22,-34.54,;15.42,-36.01,;14.47,-34.79,;13.02,-35.32,;11.75,-34.46,;10.37,-35.14,;9.1,-34.28,;7.72,-34.96,;6.45,-34.1,;5.07,-34.77,;6.55,-32.57,;13.08,-36.86,;11.98,-37.93,;12.35,-39.42,;13.83,-39.84,;14.93,-38.76,;14.56,-37.29,)| InChI=1S/C26H40N4S/c1-19(2)20-9-11-22(12-10-20)29-16-13-23(14-17-29)30-18-21(6-5-15-28-26(27)31)24-7-3-4-8-25(24)30/h3-4,7-8,18-20,22-23H,5-6,9-17H2,1-2H3,(H3,27,28,31) NBGHZUOQLIHUSD-UHFFFAOYSA-N 50514556 CHEMBL4591048 Mu-type opioid receptor Homo sapiens 382 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514556&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563699 440723138 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259077 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(\C=N\O)c2ccccc12 |r,wD:6.9,3.2,(48.18,-8.94,;47.37,-7.63,;48.1,-6.27,;45.82,-7.67,;45.02,-6.36,;43.47,-6.41,;42.74,-7.76,;43.56,-9.07,;45.09,-9.03,;41.21,-7.82,;40.48,-9.17,;38.95,-9.22,;38.13,-7.92,;38.85,-6.55,;40.39,-6.51,;36.59,-7.97,;35.65,-6.76,;34.2,-7.28,;32.93,-6.43,;32.98,-4.9,;31.76,-4.04,;34.26,-8.82,;33.15,-9.89,;33.52,-11.38,;35.01,-11.8,;36.11,-10.73,;35.74,-9.25,)| InChI=1S/C23H33N3O/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24-27)22-5-3-4-6-23(22)26/h3-6,15-18,20-21,27H,7-14H2,1-2H3 KXDZSADJKWDKCN-UHFFFAOYSA-N 50514553 CHEMBL4439811 Mu-type opioid receptor Homo sapiens 56 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514553&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188454 440723135 C02658 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259078 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)N1CCc2ccccc12 |r,wD:6.9,3.2,(8.81,-19.41,;10.12,-18.58,;11.48,-19.3,;10.05,-17.04,;11.35,-16.22,;11.29,-14.67,;9.93,-13.96,;8.62,-14.79,;8.69,-16.32,;9.85,-12.42,;8.49,-11.71,;8.42,-10.18,;9.71,-9.35,;11.08,-10.05,;11.15,-11.6,;9.64,-7.81,;10.84,-6.85,;10.3,-5.41,;8.76,-5.49,;7.68,-4.4,;6.19,-4.79,;5.79,-6.28,;6.88,-7.36,;8.35,-6.97,)| InChI=1S/C22H34N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,17-18,20-21H,7-16H2,1-2H3 FALYKCYWERAVPH-UHFFFAOYSA-N 50514548 CHEMBL4570328 Delta-type opioid receptor Homo sapiens 3070 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514548&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188459 440723130 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259079 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CO)c2ccccc12 |r,wD:6.9,3.2,(63.96,-12.85,;63.15,-11.53,;63.89,-10.17,;61.61,-11.57,;60.8,-10.27,;59.26,-10.31,;58.53,-11.66,;59.34,-12.98,;60.88,-12.93,;56.99,-11.72,;56.27,-13.07,;54.73,-13.13,;53.91,-11.82,;54.63,-10.46,;56.18,-10.41,;52.38,-11.88,;51.43,-10.66,;49.98,-11.19,;48.71,-10.33,;48.82,-8.8,;50.04,-12.73,;48.94,-13.79,;49.31,-15.29,;50.79,-15.7,;51.89,-14.63,;51.52,-13.16,)| InChI=1S/C23H34N2O/c1-17(2)18-7-9-20(10-8-18)24-13-11-21(12-14-24)25-15-19(16-26)22-5-3-4-6-23(22)25/h3-6,15,17-18,20-21,26H,7-14,16H2,1-2H3 JDXUKGDQAXGTDS-UHFFFAOYSA-N 50514540 CHEMBL4439997 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514540&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563650 440723122 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259080 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN(C)C)c2ccccc12 |r,wD:6.9,3.2,(22.93,-34.28,;22.12,-32.96,;22.85,-31.6,;20.58,-33,;19.77,-31.7,;18.22,-31.74,;17.5,-33.09,;18.31,-34.41,;19.85,-34.36,;15.96,-33.15,;15.23,-34.51,;13.7,-34.56,;12.88,-33.25,;13.6,-31.89,;15.15,-31.84,;11.35,-33.31,;10.4,-32.09,;8.95,-32.62,;7.68,-31.76,;7.78,-30.23,;6.51,-29.38,;9.16,-29.56,;9.01,-34.16,;7.91,-35.23,;8.28,-36.72,;9.76,-37.13,;10.86,-36.06,;10.49,-34.59,)| InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-15-13-23(14-16-27)28-18-21(17-26(3)4)24-7-5-6-8-25(24)28/h5-8,18-20,22-23H,9-17H2,1-4H3 WVGUPYZLPGESLO-UHFFFAOYSA-N 50514538 CHEMBL4457077 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514538&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563691 440723120 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259081 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCCC2)c2ccccc12 |r,wD:6.9,3.2,(24.25,-47.25,;23.44,-45.94,;24.17,-44.58,;21.89,-45.98,;21.09,-44.68,;19.54,-44.72,;18.81,-46.07,;19.63,-47.39,;21.16,-47.34,;17.27,-46.13,;16.55,-47.48,;15.01,-47.53,;14.19,-46.23,;14.92,-44.87,;16.46,-44.82,;12.66,-46.28,;11.71,-45.07,;10.26,-45.59,;8.99,-44.74,;7.61,-45.41,;6.25,-44.7,;5.15,-45.76,;5.82,-47.14,;7.34,-46.93,;10.32,-47.13,;9.22,-48.2,;9.59,-49.7,;11.08,-50.11,;12.17,-49.04,;11.8,-47.56,)| InChI=1S/C27H41N3/c1-21(2)22-9-11-24(12-10-22)29-17-13-25(14-18-29)30-20-23(19-28-15-5-6-16-28)26-7-3-4-8-27(26)30/h3-4,7-8,20-22,24-25H,5-6,9-19H2,1-2H3 NGKDULCWDLWYAO-UHFFFAOYSA-N 50514557 CHEMBL4541337 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514557&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578457 440723139 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259082 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(N)CC2)c2ccccc12 |r,wD:6.9,3.2,(50.68,-46.35,;49.87,-45.03,;50.61,-43.68,;48.33,-45.08,;47.52,-43.77,;45.97,-43.81,;45.24,-45.17,;46.06,-46.48,;47.59,-46.44,;43.7,-45.23,;42.98,-46.58,;41.44,-46.63,;40.62,-45.33,;41.34,-43.96,;42.89,-43.91,;39.09,-45.38,;38.14,-44.16,;36.69,-44.69,;35.42,-43.83,;34.04,-44.51,;32.77,-43.65,;31.4,-44.32,;31.28,-45.85,;29.9,-46.52,;32.56,-46.71,;33.94,-46.04,;36.75,-46.23,;35.65,-47.3,;36.02,-48.79,;37.5,-49.21,;38.6,-48.14,;38.23,-46.66,)| InChI=1S/C28H44N4/c1-21(2)22-7-9-25(10-8-22)31-17-13-26(14-18-31)32-20-23(27-5-3-4-6-28(27)32)19-30-15-11-24(29)12-16-30/h3-6,20-22,24-26H,7-19,29H2,1-2H3 QGUZGYQHAUOCCK-UHFFFAOYSA-N 50514543 CHEMBL4590786 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514543&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563500 440723125 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259083 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC(O)C2)c2ccccc12 |r,wD:6.9,3.2,(51.84,-7.48,;51.03,-6.16,;51.76,-4.81,;49.48,-6.21,;48.68,-4.9,;47.13,-4.94,;46.4,-6.3,;47.22,-7.61,;48.75,-7.57,;44.87,-6.36,;44.14,-7.71,;42.6,-7.76,;41.78,-6.46,;42.51,-5.09,;44.05,-5.04,;40.25,-6.51,;39.3,-5.29,;37.86,-5.82,;36.58,-4.96,;35.2,-5.64,;33.75,-5.14,;33.25,-6.59,;31.87,-7.26,;34.7,-7.09,;37.92,-7.36,;36.81,-8.43,;37.18,-9.92,;38.67,-10.34,;39.77,-9.27,;39.39,-7.79,)| InChI=1S/C26H39N3O/c1-19(2)20-7-9-22(10-8-20)28-13-11-23(12-14-28)29-16-21(15-27-17-24(30)18-27)25-5-3-4-6-26(25)29/h3-6,16,19-20,22-24,30H,7-15,17-18H2,1-2H3 LCHNDEARQJNFQA-UHFFFAOYSA-N 50514554 CHEMBL4556227 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514554&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563496 440723136 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259084 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(52.76,-21.76,;51.95,-20.45,;52.68,-19.09,;50.41,-20.49,;49.6,-19.19,;48.05,-19.23,;47.33,-20.58,;48.14,-21.89,;49.67,-21.85,;45.79,-20.64,;45.06,-21.99,;43.53,-22.04,;42.71,-20.74,;43.43,-19.38,;44.98,-19.33,;41.17,-20.79,;40.23,-19.58,;38.78,-20.1,;37.51,-19.25,;36.13,-19.92,;34.86,-19.07,;33.48,-19.74,;34.96,-17.54,;38.84,-21.64,;37.73,-22.71,;38.11,-24.2,;39.59,-24.62,;40.69,-23.55,;40.32,-22.07,)| InChI=1S/C24H36N4S/c1-17(2)18-7-9-20(10-8-18)27-13-11-21(12-14-27)28-16-19(15-26-24(25)29)22-5-3-4-6-23(22)28/h3-6,16-18,20-21H,7-15H2,1-2H3,(H3,25,26,29) BTZMBSYIWRQRBI-UHFFFAOYSA-N 50514539 CHEMBL4460695 Delta-type opioid receptor Homo sapiens 4067 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514539&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563466 440723121 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259085 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(77.5,-21.25,;76.69,-19.93,;77.42,-18.58,;75.15,-19.98,;74.34,-18.67,;72.79,-18.71,;72.06,-20.07,;72.88,-21.38,;74.41,-21.34,;70.53,-20.13,;69.8,-21.48,;68.27,-21.53,;67.45,-20.23,;68.17,-18.86,;69.71,-18.81,;65.91,-20.28,;64.97,-19.06,;63.52,-19.59,;62.24,-18.73,;60.87,-19.41,;59.59,-18.55,;58.21,-19.23,;56.94,-18.37,;58.11,-20.76,;63.58,-21.13,;62.47,-22.2,;62.84,-23.69,;64.33,-24.11,;65.43,-23.04,;65.06,-21.56,)| InChI=1S/C25H38N4S/c1-18(2)19-7-9-21(10-8-19)28-15-12-22(13-16-28)29-17-20(11-14-27-25(26)30)23-5-3-4-6-24(23)29/h3-6,17-19,21-22H,7-16H2,1-2H3,(H3,26,27,30) SDNMVMVANFPUFO-UHFFFAOYSA-N 50514555 CHEMBL4467156 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514555&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563698 440723137 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259086 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)CCCCCN)c2ccccc12 |r,wD:6.9,3.2,(30.71,-51.51,;29.9,-50.19,;30.64,-48.83,;28.36,-50.23,;27.55,-48.92,;26,-48.97,;25.27,-50.32,;26.09,-51.64,;27.62,-51.59,;23.73,-50.38,;23,-51.74,;21.47,-51.79,;20.64,-50.48,;21.37,-49.12,;22.92,-49.07,;19.11,-50.54,;18.16,-49.32,;16.71,-49.84,;15.44,-48.99,;14.06,-49.66,;12.78,-48.81,;12.89,-47.27,;11.4,-49.48,;10.13,-48.62,;8.75,-49.3,;7.47,-48.44,;6.09,-49.12,;4.82,-48.26,;16.77,-51.39,;15.66,-52.46,;16.04,-53.95,;17.52,-54.37,;18.62,-53.29,;18.25,-51.82,)| InChI=1S/C29H46N4O/c1-22(2)23-11-13-25(14-12-23)32-18-15-26(16-19-32)33-21-24(27-8-5-6-9-28(27)33)20-31-29(34)10-4-3-7-17-30/h5-6,8-9,21-23,25-26H,3-4,7,10-20,30H2,1-2H3,(H,31,34) ZUGCJUUUBNUVGL-UHFFFAOYSA-N 50514546 CHEMBL4521436 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514546&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155542684 440723128 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259087 CCNCC(=O)NCc1cn(C2CCN(CC2)[C@@H]2CC[C@@H](CC2)C(C)C)c2ccccc12 |r,wD:17.17,20.24,(39.61,-48.97,;40.88,-49.83,;42.26,-49.15,;43.53,-50.01,;44.91,-49.33,;45.02,-47.8,;46.19,-50.19,;47.56,-49.51,;48.84,-50.37,;50.29,-49.84,;51.23,-51.06,;52.77,-51,;53.59,-52.31,;55.12,-52.26,;55.85,-50.9,;55.04,-49.59,;53.49,-49.64,;57.39,-50.84,;58.11,-49.49,;59.66,-49.45,;60.47,-50.76,;59.74,-52.11,;58.2,-52.16,;62.01,-50.71,;62.82,-52.03,;62.75,-49.36,;50.38,-52.34,;50.75,-53.81,;49.65,-54.89,;48.16,-54.47,;47.79,-52.98,;48.9,-51.91,)| InChI=1S/C27H42N4O/c1-4-28-18-27(32)29-17-22-19-31(26-8-6-5-7-25(22)26)24-13-15-30(16-14-24)23-11-9-21(10-12-23)20(2)3/h5-8,19-21,23-24,28H,4,9-18H2,1-3H3,(H,29,32) ADBGQUWNDQPXSG-UHFFFAOYSA-N 50514558 CHEMBL4519453 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514558&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578342 440723140 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259088 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(\C=N\O)c2ccccc12 |r,wD:6.9,3.2,(48.18,-8.94,;47.37,-7.63,;48.1,-6.27,;45.82,-7.67,;45.02,-6.36,;43.47,-6.41,;42.74,-7.76,;43.56,-9.07,;45.09,-9.03,;41.21,-7.82,;40.48,-9.17,;38.95,-9.22,;38.13,-7.92,;38.85,-6.55,;40.39,-6.51,;36.59,-7.97,;35.65,-6.76,;34.2,-7.28,;32.93,-6.43,;32.98,-4.9,;31.76,-4.04,;34.26,-8.82,;33.15,-9.89,;33.52,-11.38,;35.01,-11.8,;36.11,-10.73,;35.74,-9.25,)| InChI=1S/C23H33N3O/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24-27)22-5-3-4-6-23(22)26/h3-6,15-18,20-21,27H,7-14H2,1-2H3 KXDZSADJKWDKCN-UHFFFAOYSA-N 50514553 CHEMBL4439811 Delta-type opioid receptor Homo sapiens 1690 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514553&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188454 440723135 C02658 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259089 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CO)c2ccccc12 |r,wD:6.9,3.2,(63.96,-12.85,;63.15,-11.53,;63.89,-10.17,;61.61,-11.57,;60.8,-10.27,;59.26,-10.31,;58.53,-11.66,;59.34,-12.98,;60.88,-12.93,;56.99,-11.72,;56.27,-13.07,;54.73,-13.13,;53.91,-11.82,;54.63,-10.46,;56.18,-10.41,;52.38,-11.88,;51.43,-10.66,;49.98,-11.19,;48.71,-10.33,;48.82,-8.8,;50.04,-12.73,;48.94,-13.79,;49.31,-15.29,;50.79,-15.7,;51.89,-14.63,;51.52,-13.16,)| InChI=1S/C23H34N2O/c1-17(2)18-7-9-20(10-8-18)24-13-11-21(12-14-24)25-15-19(16-26)22-5-3-4-6-23(22)25/h3-6,15,17-18,20-21,26H,7-14,16H2,1-2H3 JDXUKGDQAXGTDS-UHFFFAOYSA-N 50514540 CHEMBL4439997 Kappa-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514540&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563650 440723122 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259090 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN(C)C)c2ccccc12 |r,wD:6.9,3.2,(22.93,-34.28,;22.12,-32.96,;22.85,-31.6,;20.58,-33,;19.77,-31.7,;18.22,-31.74,;17.5,-33.09,;18.31,-34.41,;19.85,-34.36,;15.96,-33.15,;15.23,-34.51,;13.7,-34.56,;12.88,-33.25,;13.6,-31.89,;15.15,-31.84,;11.35,-33.31,;10.4,-32.09,;8.95,-32.62,;7.68,-31.76,;7.78,-30.23,;6.51,-29.38,;9.16,-29.56,;9.01,-34.16,;7.91,-35.23,;8.28,-36.72,;9.76,-37.13,;10.86,-36.06,;10.49,-34.59,)| InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-15-13-23(14-16-27)28-18-21(17-26(3)4)24-7-5-6-8-25(24)28/h5-8,18-20,22-23H,9-17H2,1-4H3 WVGUPYZLPGESLO-UHFFFAOYSA-N 50514538 CHEMBL4457077 Kappa-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514538&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563691 440723120 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259091 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCN)c2ccccc12 InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-16-13-23(14-17-27)28-18-21(6-5-15-26)24-7-3-4-8-25(24)28/h3-4,7-8,18-20,22-23H,5-6,9-17,26H2,1-2H3 SJRTYDYZXKADCH-UHFFFAOYSA-N 50514547 CHEMBL4451073 Kappa-type opioid receptor Homo sapiens 1320 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514547&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563704 440723129 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259092 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCCC2)c2ccccc12 |r,wD:6.9,3.2,(24.25,-47.25,;23.44,-45.94,;24.17,-44.58,;21.89,-45.98,;21.09,-44.68,;19.54,-44.72,;18.81,-46.07,;19.63,-47.39,;21.16,-47.34,;17.27,-46.13,;16.55,-47.48,;15.01,-47.53,;14.19,-46.23,;14.92,-44.87,;16.46,-44.82,;12.66,-46.28,;11.71,-45.07,;10.26,-45.59,;8.99,-44.74,;7.61,-45.41,;6.25,-44.7,;5.15,-45.76,;5.82,-47.14,;7.34,-46.93,;10.32,-47.13,;9.22,-48.2,;9.59,-49.7,;11.08,-50.11,;12.17,-49.04,;11.8,-47.56,)| InChI=1S/C27H41N3/c1-21(2)22-9-11-24(12-10-22)29-17-13-25(14-18-29)30-20-23(19-28-15-5-6-16-28)26-7-3-4-8-27(26)30/h3-4,7-8,20-22,24-25H,5-6,9-19H2,1-2H3 NGKDULCWDLWYAO-UHFFFAOYSA-N 50514557 CHEMBL4541337 Kappa-type opioid receptor Homo sapiens 461 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514557&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578457 440723139 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259093 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(O)CC2)c2ccccc12 |r,wD:6.9,3.2,(75.58,-45.79,;74.76,-44.48,;75.5,-43.12,;73.22,-44.52,;72.41,-43.21,;70.87,-43.26,;70.14,-44.61,;70.95,-45.93,;72.49,-45.88,;68.6,-44.67,;67.87,-46.02,;66.34,-46.07,;65.52,-44.77,;66.24,-43.41,;67.79,-43.36,;63.98,-44.82,;63.04,-43.61,;61.59,-44.13,;60.32,-43.28,;58.94,-43.95,;57.67,-43.09,;56.29,-43.76,;56.18,-45.29,;54.8,-45.96,;57.45,-46.15,;58.84,-45.48,;61.65,-45.67,;60.54,-46.74,;60.91,-48.24,;62.4,-48.65,;63.5,-47.58,;63.13,-46.1,)| InChI=1S/C28H43N3O/c1-21(2)22-7-9-24(10-8-22)30-17-11-25(12-18-30)31-20-23(27-5-3-4-6-28(27)31)19-29-15-13-26(32)14-16-29/h3-6,20-22,24-26,32H,7-19H2,1-2H3 PCXCVPKTSPZHJW-UHFFFAOYSA-N 50514551 CHEMBL4550088 Kappa-type opioid receptor Homo sapiens 3840 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514551&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578506 440723133 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259094 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNCCO)c2ccccc12 |r,wD:6.9,3.2,(27.23,-22.87,;26.41,-21.55,;27.15,-20.19,;24.87,-21.59,;24.06,-20.29,;22.52,-20.33,;21.79,-21.68,;22.61,-23,;24.14,-22.95,;20.25,-21.74,;19.53,-23.1,;17.99,-23.15,;17.17,-21.84,;17.9,-20.48,;19.44,-20.43,;15.64,-21.9,;14.69,-20.68,;13.25,-21.21,;11.97,-20.35,;10.59,-21.03,;9.32,-20.17,;7.94,-20.84,;6.67,-19.99,;13.3,-22.75,;12.2,-23.82,;12.57,-25.31,;14.06,-25.72,;15.16,-24.65,;14.78,-23.18,)| InChI=1S/C25H39N3O/c1-19(2)20-7-9-22(10-8-20)27-14-11-23(12-15-27)28-18-21(17-26-13-16-29)24-5-3-4-6-25(24)28/h3-6,18-20,22-23,26,29H,7-17H2,1-2H3 MWMHYNCBTDRUCG-UHFFFAOYSA-N 50514544 CHEMBL4518220 Kappa-type opioid receptor Homo sapiens 1490 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514544&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578518 440723126 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259095 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(52.76,-21.76,;51.95,-20.45,;52.68,-19.09,;50.41,-20.49,;49.6,-19.19,;48.05,-19.23,;47.33,-20.58,;48.14,-21.89,;49.67,-21.85,;45.79,-20.64,;45.06,-21.99,;43.53,-22.04,;42.71,-20.74,;43.43,-19.38,;44.98,-19.33,;41.17,-20.79,;40.23,-19.58,;38.78,-20.1,;37.51,-19.25,;36.13,-19.92,;34.86,-19.07,;33.48,-19.74,;34.96,-17.54,;38.84,-21.64,;37.73,-22.71,;38.11,-24.2,;39.59,-24.62,;40.69,-23.55,;40.32,-22.07,)| InChI=1S/C24H36N4S/c1-17(2)18-7-9-20(10-8-18)27-13-11-21(12-14-27)28-16-19(15-26-24(25)29)22-5-3-4-6-23(22)28/h3-6,16-18,20-21H,7-15H2,1-2H3,(H3,25,26,29) BTZMBSYIWRQRBI-UHFFFAOYSA-N 50514539 CHEMBL4460695 Kappa-type opioid receptor Homo sapiens 1328 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514539&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563466 440723121 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259096 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)[C@@H](N)CCCNC(N)=N)c2ccccc12 |r,wU:22.24,wD:6.9,3.2,(63.55,-38.33,;62.74,-37.01,;63.48,-35.65,;61.19,-37.05,;60.38,-35.75,;58.84,-35.79,;58.11,-37.14,;58.92,-38.46,;60.46,-38.41,;56.57,-37.2,;55.84,-38.56,;54.3,-38.61,;53.48,-37.3,;54.2,-35.94,;55.75,-35.89,;51.94,-37.36,;51,-36.14,;49.55,-36.67,;48.27,-35.81,;46.89,-36.48,;45.62,-35.63,;45.72,-34.09,;44.24,-36.3,;44.13,-37.84,;42.96,-35.45,;41.58,-36.12,;40.3,-35.26,;38.92,-35.94,;37.65,-35.08,;36.27,-35.76,;37.75,-33.55,;49.61,-38.21,;48.5,-39.28,;48.87,-40.77,;50.36,-41.19,;51.46,-40.12,;51.09,-38.64,)| InChI=1S/C29H47N7O/c1-20(2)21-9-11-23(12-10-21)35-16-13-24(14-17-35)36-19-22(25-6-3-4-8-27(25)36)18-34-28(37)26(30)7-5-15-33-29(31)32/h3-4,6,8,19-21,23-24,26H,5,7,9-18,30H2,1-2H3,(H,34,37)(H4,31,32,33) WLQVWCBBPYAMOQ-UHFFFAOYSA-N 50514552 CHEMBL4594096 Kappa-type opioid receptor Homo sapiens 674 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514552&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155569552 440723134 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259097 CCNCC(=O)NCc1cn(C2CCN(CC2)[C@@H]2CC[C@@H](CC2)C(C)C)c2ccccc12 |r,wD:17.17,20.24,(39.61,-48.97,;40.88,-49.83,;42.26,-49.15,;43.53,-50.01,;44.91,-49.33,;45.02,-47.8,;46.19,-50.19,;47.56,-49.51,;48.84,-50.37,;50.29,-49.84,;51.23,-51.06,;52.77,-51,;53.59,-52.31,;55.12,-52.26,;55.85,-50.9,;55.04,-49.59,;53.49,-49.64,;57.39,-50.84,;58.11,-49.49,;59.66,-49.45,;60.47,-50.76,;59.74,-52.11,;58.2,-52.16,;62.01,-50.71,;62.82,-52.03,;62.75,-49.36,;50.38,-52.34,;50.75,-53.81,;49.65,-54.89,;48.16,-54.47,;47.79,-52.98,;48.9,-51.91,)| InChI=1S/C27H42N4O/c1-4-28-18-27(32)29-17-22-19-31(26-8-6-5-7-25(22)26)24-13-15-30(16-14-24)23-11-9-21(10-12-23)20(2)3/h5-8,19-21,23-24,28H,4,9-18H2,1-3H3,(H,29,32) ADBGQUWNDQPXSG-UHFFFAOYSA-N 50514558 CHEMBL4519453 Kappa-type opioid receptor Homo sapiens 1440 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514558&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578342 440723140 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259098 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(\C=N\O)c2ccccc12 |r,wD:6.9,3.2,(48.18,-8.94,;47.37,-7.63,;48.1,-6.27,;45.82,-7.67,;45.02,-6.36,;43.47,-6.41,;42.74,-7.76,;43.56,-9.07,;45.09,-9.03,;41.21,-7.82,;40.48,-9.17,;38.95,-9.22,;38.13,-7.92,;38.85,-6.55,;40.39,-6.51,;36.59,-7.97,;35.65,-6.76,;34.2,-7.28,;32.93,-6.43,;32.98,-4.9,;31.76,-4.04,;34.26,-8.82,;33.15,-9.89,;33.52,-11.38,;35.01,-11.8,;36.11,-10.73,;35.74,-9.25,)| InChI=1S/C23H33N3O/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24-27)22-5-3-4-6-23(22)26/h3-6,15-18,20-21,27H,7-14H2,1-2H3 KXDZSADJKWDKCN-UHFFFAOYSA-N 50514553 CHEMBL4439811 Kappa-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514553&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188454 440723135 C02658 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259099 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1ccc2ccccc12 |r,wD:6.9,3.2,(20.66,-19.76,;21.96,-18.93,;23.33,-19.65,;21.9,-17.39,;23.2,-16.56,;23.13,-15.02,;21.77,-14.31,;20.47,-15.14,;20.53,-16.67,;21.69,-12.77,;20.33,-12.06,;20.26,-10.53,;21.56,-9.69,;22.93,-10.4,;23,-11.94,;21.48,-8.16,;22.69,-7.2,;22.14,-5.76,;20.61,-5.84,;19.52,-4.75,;18.04,-5.14,;17.64,-6.63,;18.72,-7.71,;20.19,-7.32,)| InChI=1S/C22H32N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,11,16-18,20-21H,7-10,12-15H2,1-2H3 RUVSOGDMGUPNJT-UHFFFAOYSA-N 50514545 CHEMBL4435280 Nociceptin receptor Homo sapiens 160 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514545&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188443 440723127 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259100 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN)c2ccccc12 |r,wD:6.9,3.2,(34,-19.87,;35.3,-19.05,;36.67,-19.77,;35.24,-17.51,;36.54,-16.68,;36.48,-15.14,;35.12,-14.43,;33.81,-15.26,;33.88,-16.79,;35.04,-12.89,;33.68,-12.18,;33.61,-10.65,;34.9,-9.81,;36.27,-10.52,;36.34,-12.06,;34.83,-8.28,;36.03,-7.32,;35.49,-5.88,;36.33,-4.59,;37.86,-4.68,;33.95,-5.95,;32.87,-4.86,;31.38,-5.25,;30.98,-6.74,;32.07,-7.83,;33.54,-7.44,)| InChI=1S/C23H35N3/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24)22-5-3-4-6-23(22)26/h3-6,16-18,20-21H,7-15,24H2,1-2H3 IPYIZXVSNKMLOX-UHFFFAOYSA-N 50514549 CHEMBL4548515 Nociceptin receptor Homo sapiens 121 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514549&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563655 440723131 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259101 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN(C)C)c2ccccc12 |r,wD:6.9,3.2,(22.93,-34.28,;22.12,-32.96,;22.85,-31.6,;20.58,-33,;19.77,-31.7,;18.22,-31.74,;17.5,-33.09,;18.31,-34.41,;19.85,-34.36,;15.96,-33.15,;15.23,-34.51,;13.7,-34.56,;12.88,-33.25,;13.6,-31.89,;15.15,-31.84,;11.35,-33.31,;10.4,-32.09,;8.95,-32.62,;7.68,-31.76,;7.78,-30.23,;6.51,-29.38,;9.16,-29.56,;9.01,-34.16,;7.91,-35.23,;8.28,-36.72,;9.76,-37.13,;10.86,-36.06,;10.49,-34.59,)| InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-15-13-23(14-16-27)28-18-21(17-26(3)4)24-7-5-6-8-25(24)28/h5-8,18-20,22-23H,9-17H2,1-4H3 WVGUPYZLPGESLO-UHFFFAOYSA-N 50514538 CHEMBL4457077 Nociceptin receptor Homo sapiens 532 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514538&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563691 440723120 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259102 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCCC2)c2ccccc12 |r,wD:6.9,3.2,(24.25,-47.25,;23.44,-45.94,;24.17,-44.58,;21.89,-45.98,;21.09,-44.68,;19.54,-44.72,;18.81,-46.07,;19.63,-47.39,;21.16,-47.34,;17.27,-46.13,;16.55,-47.48,;15.01,-47.53,;14.19,-46.23,;14.92,-44.87,;16.46,-44.82,;12.66,-46.28,;11.71,-45.07,;10.26,-45.59,;8.99,-44.74,;7.61,-45.41,;6.25,-44.7,;5.15,-45.76,;5.82,-47.14,;7.34,-46.93,;10.32,-47.13,;9.22,-48.2,;9.59,-49.7,;11.08,-50.11,;12.17,-49.04,;11.8,-47.56,)| InChI=1S/C27H41N3/c1-21(2)22-9-11-24(12-10-22)29-17-13-25(14-18-29)30-20-23(19-28-15-5-6-16-28)26-7-3-4-8-27(26)30/h3-4,7-8,20-22,24-25H,5-6,9-19H2,1-2H3 NGKDULCWDLWYAO-UHFFFAOYSA-N 50514557 CHEMBL4541337 Nociceptin receptor Homo sapiens 97 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514557&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578457 440723139 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259103 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC[C@@H](O)C2)c2ccccc12 |r,wD:6.9,3.2,22.24,(23.74,-8.52,;22.92,-7.21,;23.66,-5.85,;21.38,-7.25,;20.57,-5.95,;19.03,-5.99,;18.3,-7.34,;19.12,-8.66,;20.65,-8.61,;16.76,-7.4,;16.04,-8.75,;14.5,-8.81,;13.68,-7.5,;14.4,-6.14,;15.95,-6.09,;12.15,-7.56,;11.2,-6.34,;9.75,-6.87,;8.48,-6.01,;7.1,-6.68,;5.74,-5.97,;4.64,-7.04,;5.31,-8.41,;4.59,-9.77,;6.83,-8.2,;9.81,-8.41,;8.71,-9.47,;9.08,-10.97,;10.56,-11.38,;11.66,-10.31,;11.29,-8.84,)| InChI=1S/C27H41N3O/c1-20(2)21-7-9-23(10-8-21)29-15-11-24(12-16-29)30-18-22(17-28-14-13-25(31)19-28)26-5-3-4-6-27(26)30/h3-6,18,20-21,23-25,31H,7-17,19H2,1-2H3 UVJCSVMAXSVVJZ-UHFFFAOYSA-N 50514541 CHEMBL4473045 Nociceptin receptor Homo sapiens 575 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514541&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578456 440723123 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259104 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(77.5,-21.25,;76.69,-19.93,;77.42,-18.58,;75.15,-19.98,;74.34,-18.67,;72.79,-18.71,;72.06,-20.07,;72.88,-21.38,;74.41,-21.34,;70.53,-20.13,;69.8,-21.48,;68.27,-21.53,;67.45,-20.23,;68.17,-18.86,;69.71,-18.81,;65.91,-20.28,;64.97,-19.06,;63.52,-19.59,;62.24,-18.73,;60.87,-19.41,;59.59,-18.55,;58.21,-19.23,;56.94,-18.37,;58.11,-20.76,;63.58,-21.13,;62.47,-22.2,;62.84,-23.69,;64.33,-24.11,;65.43,-23.04,;65.06,-21.56,)| InChI=1S/C25H38N4S/c1-18(2)19-7-9-21(10-8-19)28-15-12-22(13-16-28)29-17-20(11-14-27-25(26)30)23-5-3-4-6-24(23)29/h3-6,17-19,21-22H,7-16H2,1-2H3,(H3,26,27,30) SDNMVMVANFPUFO-UHFFFAOYSA-N 50514555 CHEMBL4467156 Nociceptin receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514555&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563698 440723137 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259105 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(27.01,-36.98,;26.19,-35.66,;26.93,-34.3,;24.65,-35.71,;23.85,-34.4,;22.3,-34.44,;21.57,-35.79,;22.39,-37.11,;23.92,-37.06,;20.03,-35.85,;19.31,-37.21,;17.77,-37.26,;16.95,-35.95,;17.67,-34.59,;19.22,-34.54,;15.42,-36.01,;14.47,-34.79,;13.02,-35.32,;11.75,-34.46,;10.37,-35.14,;9.1,-34.28,;7.72,-34.96,;6.45,-34.1,;5.07,-34.77,;6.55,-32.57,;13.08,-36.86,;11.98,-37.93,;12.35,-39.42,;13.83,-39.84,;14.93,-38.76,;14.56,-37.29,)| InChI=1S/C26H40N4S/c1-19(2)20-9-11-22(12-10-20)29-16-13-23(14-17-29)30-18-21(6-5-15-28-26(27)31)24-7-3-4-8-25(24)30/h3-4,7-8,18-20,22-23H,5-6,9-17H2,1-2H3,(H3,27,28,31) NBGHZUOQLIHUSD-UHFFFAOYSA-N 50514556 CHEMBL4591048 Nociceptin receptor Homo sapiens 175 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514556&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563699 440723138 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259106 CCNCC(=O)NCc1cn(C2CCN(CC2)[C@@H]2CC[C@@H](CC2)C(C)C)c2ccccc12 |r,wD:17.17,20.24,(39.61,-48.97,;40.88,-49.83,;42.26,-49.15,;43.53,-50.01,;44.91,-49.33,;45.02,-47.8,;46.19,-50.19,;47.56,-49.51,;48.84,-50.37,;50.29,-49.84,;51.23,-51.06,;52.77,-51,;53.59,-52.31,;55.12,-52.26,;55.85,-50.9,;55.04,-49.59,;53.49,-49.64,;57.39,-50.84,;58.11,-49.49,;59.66,-49.45,;60.47,-50.76,;59.74,-52.11,;58.2,-52.16,;62.01,-50.71,;62.82,-52.03,;62.75,-49.36,;50.38,-52.34,;50.75,-53.81,;49.65,-54.89,;48.16,-54.47,;47.79,-52.98,;48.9,-51.91,)| InChI=1S/C27H42N4O/c1-4-28-18-27(32)29-17-22-19-31(26-8-6-5-7-25(22)26)24-13-15-30(16-14-24)23-11-9-21(10-12-23)20(2)3/h5-8,19-21,23-24,28H,4,9-18H2,1-3H3,(H,29,32) ADBGQUWNDQPXSG-UHFFFAOYSA-N 50514558 CHEMBL4519453 Nociceptin receptor Homo sapiens 277 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514558&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578342 440723140 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259107 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(\C=N\O)c2ccccc12 |r,wD:6.9,3.2,(48.18,-8.94,;47.37,-7.63,;48.1,-6.27,;45.82,-7.67,;45.02,-6.36,;43.47,-6.41,;42.74,-7.76,;43.56,-9.07,;45.09,-9.03,;41.21,-7.82,;40.48,-9.17,;38.95,-9.22,;38.13,-7.92,;38.85,-6.55,;40.39,-6.51,;36.59,-7.97,;35.65,-6.76,;34.2,-7.28,;32.93,-6.43,;32.98,-4.9,;31.76,-4.04,;34.26,-8.82,;33.15,-9.89,;33.52,-11.38,;35.01,-11.8,;36.11,-10.73,;35.74,-9.25,)| InChI=1S/C23H33N3O/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24-27)22-5-3-4-6-23(22)26/h3-6,15-18,20-21,27H,7-14H2,1-2H3 KXDZSADJKWDKCN-UHFFFAOYSA-N 50514553 CHEMBL4439811 Nociceptin receptor Homo sapiens 67 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514553&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188454 440723135 C02658 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259108 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN)c2ccccc12 |r,wD:6.9,3.2,(34,-19.87,;35.3,-19.05,;36.67,-19.77,;35.24,-17.51,;36.54,-16.68,;36.48,-15.14,;35.12,-14.43,;33.81,-15.26,;33.88,-16.79,;35.04,-12.89,;33.68,-12.18,;33.61,-10.65,;34.9,-9.81,;36.27,-10.52,;36.34,-12.06,;34.83,-8.28,;36.03,-7.32,;35.49,-5.88,;36.33,-4.59,;37.86,-4.68,;33.95,-5.95,;32.87,-4.86,;31.38,-5.25,;30.98,-6.74,;32.07,-7.83,;33.54,-7.44,)| InChI=1S/C23H35N3/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24)22-5-3-4-6-23(22)26/h3-6,16-18,20-21H,7-15,24H2,1-2H3 IPYIZXVSNKMLOX-UHFFFAOYSA-N 50514549 CHEMBL4548515 Mu-type opioid receptor Homo sapiens 105 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514549&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563655 440723131 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259109 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(52.76,-21.76,;51.95,-20.45,;52.68,-19.09,;50.41,-20.49,;49.6,-19.19,;48.05,-19.23,;47.33,-20.58,;48.14,-21.89,;49.67,-21.85,;45.79,-20.64,;45.06,-21.99,;43.53,-22.04,;42.71,-20.74,;43.43,-19.38,;44.98,-19.33,;41.17,-20.79,;40.23,-19.58,;38.78,-20.1,;37.51,-19.25,;36.13,-19.92,;34.86,-19.07,;33.48,-19.74,;34.96,-17.54,;38.84,-21.64,;37.73,-22.71,;38.11,-24.2,;39.59,-24.62,;40.69,-23.55,;40.32,-22.07,)| InChI=1S/C24H36N4S/c1-17(2)18-7-9-20(10-8-18)27-13-11-21(12-14-27)28-16-19(15-26-24(25)29)22-5-3-4-6-23(22)28/h3-6,16-18,20-21H,7-15H2,1-2H3,(H3,25,26,29) BTZMBSYIWRQRBI-UHFFFAOYSA-N 50514539 CHEMBL4460695 Mu-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514539&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563466 440723121 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259110 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(\C=N\O)c2ccccc12 |r,wD:6.9,3.2,(48.18,-8.94,;47.37,-7.63,;48.1,-6.27,;45.82,-7.67,;45.02,-6.36,;43.47,-6.41,;42.74,-7.76,;43.56,-9.07,;45.09,-9.03,;41.21,-7.82,;40.48,-9.17,;38.95,-9.22,;38.13,-7.92,;38.85,-6.55,;40.39,-6.51,;36.59,-7.97,;35.65,-6.76,;34.2,-7.28,;32.93,-6.43,;32.98,-4.9,;31.76,-4.04,;34.26,-8.82,;33.15,-9.89,;33.52,-11.38,;35.01,-11.8,;36.11,-10.73,;35.74,-9.25,)| InChI=1S/C23H33N3O/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24-27)22-5-3-4-6-23(22)26/h3-6,15-18,20-21,27H,7-14H2,1-2H3 KXDZSADJKWDKCN-UHFFFAOYSA-N 50514553 CHEMBL4439811 Mu-type opioid receptor Homo sapiens 3199 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514553&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188454 440723135 C02658 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259111 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)[C@@H](N)CCCNC(N)=N)c2ccccc12 |r,wU:22.24,wD:6.9,3.2,(63.55,-38.33,;62.74,-37.01,;63.48,-35.65,;61.19,-37.05,;60.38,-35.75,;58.84,-35.79,;58.11,-37.14,;58.92,-38.46,;60.46,-38.41,;56.57,-37.2,;55.84,-38.56,;54.3,-38.61,;53.48,-37.3,;54.2,-35.94,;55.75,-35.89,;51.94,-37.36,;51,-36.14,;49.55,-36.67,;48.27,-35.81,;46.89,-36.48,;45.62,-35.63,;45.72,-34.09,;44.24,-36.3,;44.13,-37.84,;42.96,-35.45,;41.58,-36.12,;40.3,-35.26,;38.92,-35.94,;37.65,-35.08,;36.27,-35.76,;37.75,-33.55,;49.61,-38.21,;48.5,-39.28,;48.87,-40.77,;50.36,-41.19,;51.46,-40.12,;51.09,-38.64,)| InChI=1S/C29H47N7O/c1-20(2)21-9-11-23(12-10-21)35-16-13-24(14-17-35)36-19-22(25-6-3-4-8-27(25)36)18-34-28(37)26(30)7-5-15-33-29(31)32/h3-4,6,8,19-21,23-24,26H,5,7,9-18,30H2,1-2H3,(H,34,37)(H4,31,32,33) WLQVWCBBPYAMOQ-UHFFFAOYSA-N 50514552 CHEMBL4594096 Nociceptin receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514552&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 155569552 440723134 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259112 CCNCC(=O)NCc1cn(C2CCN(CC2)[C@@H]2CC[C@@H](CC2)C(C)C)c2ccccc12 |r,wD:17.17,20.24,(39.61,-48.97,;40.88,-49.83,;42.26,-49.15,;43.53,-50.01,;44.91,-49.33,;45.02,-47.8,;46.19,-50.19,;47.56,-49.51,;48.84,-50.37,;50.29,-49.84,;51.23,-51.06,;52.77,-51,;53.59,-52.31,;55.12,-52.26,;55.85,-50.9,;55.04,-49.59,;53.49,-49.64,;57.39,-50.84,;58.11,-49.49,;59.66,-49.45,;60.47,-50.76,;59.74,-52.11,;58.2,-52.16,;62.01,-50.71,;62.82,-52.03,;62.75,-49.36,;50.38,-52.34,;50.75,-53.81,;49.65,-54.89,;48.16,-54.47,;47.79,-52.98,;48.9,-51.91,)| InChI=1S/C27H42N4O/c1-4-28-18-27(32)29-17-22-19-31(26-8-6-5-7-25(22)26)24-13-15-30(16-14-24)23-11-9-21(10-12-23)20(2)3/h5-8,19-21,23-24,28H,4,9-18H2,1-3H3,(H,29,32) ADBGQUWNDQPXSG-UHFFFAOYSA-N 50514558 CHEMBL4519453 Mu-type opioid receptor Homo sapiens 269 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514558&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578342 440723140 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259113 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CO)c2ccccc12 |r,wD:6.9,3.2,(63.96,-12.85,;63.15,-11.53,;63.89,-10.17,;61.61,-11.57,;60.8,-10.27,;59.26,-10.31,;58.53,-11.66,;59.34,-12.98,;60.88,-12.93,;56.99,-11.72,;56.27,-13.07,;54.73,-13.13,;53.91,-11.82,;54.63,-10.46,;56.18,-10.41,;52.38,-11.88,;51.43,-10.66,;49.98,-11.19,;48.71,-10.33,;48.82,-8.8,;50.04,-12.73,;48.94,-13.79,;49.31,-15.29,;50.79,-15.7,;51.89,-14.63,;51.52,-13.16,)| InChI=1S/C23H34N2O/c1-17(2)18-7-9-20(10-8-18)24-13-11-21(12-14-24)25-15-19(16-26)22-5-3-4-6-23(22)25/h3-6,15,17-18,20-21,26H,7-14,16H2,1-2H3 JDXUKGDQAXGTDS-UHFFFAOYSA-N 50514540 CHEMBL4439997 Nociceptin receptor Homo sapiens 45 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514540&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563650 440723122 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259114 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(N)CC2)c2ccccc12 |r,wD:6.9,3.2,(50.68,-46.35,;49.87,-45.03,;50.61,-43.68,;48.33,-45.08,;47.52,-43.77,;45.97,-43.81,;45.24,-45.17,;46.06,-46.48,;47.59,-46.44,;43.7,-45.23,;42.98,-46.58,;41.44,-46.63,;40.62,-45.33,;41.34,-43.96,;42.89,-43.91,;39.09,-45.38,;38.14,-44.16,;36.69,-44.69,;35.42,-43.83,;34.04,-44.51,;32.77,-43.65,;31.4,-44.32,;31.28,-45.85,;29.9,-46.52,;32.56,-46.71,;33.94,-46.04,;36.75,-46.23,;35.65,-47.3,;36.02,-48.79,;37.5,-49.21,;38.6,-48.14,;38.23,-46.66,)| InChI=1S/C28H44N4/c1-21(2)22-7-9-25(10-8-22)31-17-13-26(14-18-31)32-20-23(27-5-3-4-6-28(27)32)19-30-15-11-24(29)12-16-30/h3-6,20-22,24-26H,7-19,29H2,1-2H3 QGUZGYQHAUOCCK-UHFFFAOYSA-N 50514543 CHEMBL4590786 Nociceptin receptor Homo sapiens 216 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514543&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563500 440723125 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259115 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(77.5,-21.25,;76.69,-19.93,;77.42,-18.58,;75.15,-19.98,;74.34,-18.67,;72.79,-18.71,;72.06,-20.07,;72.88,-21.38,;74.41,-21.34,;70.53,-20.13,;69.8,-21.48,;68.27,-21.53,;67.45,-20.23,;68.17,-18.86,;69.71,-18.81,;65.91,-20.28,;64.97,-19.06,;63.52,-19.59,;62.24,-18.73,;60.87,-19.41,;59.59,-18.55,;58.21,-19.23,;56.94,-18.37,;58.11,-20.76,;63.58,-21.13,;62.47,-22.2,;62.84,-23.69,;64.33,-24.11,;65.43,-23.04,;65.06,-21.56,)| InChI=1S/C25H38N4S/c1-18(2)19-7-9-21(10-8-19)28-15-12-22(13-16-28)29-17-20(11-14-27-25(26)30)23-5-3-4-6-24(23)29/h3-6,17-19,21-22H,7-16H2,1-2H3,(H3,26,27,30) SDNMVMVANFPUFO-UHFFFAOYSA-N 50514555 CHEMBL4467156 Nociceptin receptor Homo sapiens 24 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514555&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563698 440723137 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259116 CCNCC(=O)NCc1cn(C2CCN(CC2)[C@@H]2CC[C@@H](CC2)C(C)C)c2ccccc12 |r,wD:17.17,20.24,(39.61,-48.97,;40.88,-49.83,;42.26,-49.15,;43.53,-50.01,;44.91,-49.33,;45.02,-47.8,;46.19,-50.19,;47.56,-49.51,;48.84,-50.37,;50.29,-49.84,;51.23,-51.06,;52.77,-51,;53.59,-52.31,;55.12,-52.26,;55.85,-50.9,;55.04,-49.59,;53.49,-49.64,;57.39,-50.84,;58.11,-49.49,;59.66,-49.45,;60.47,-50.76,;59.74,-52.11,;58.2,-52.16,;62.01,-50.71,;62.82,-52.03,;62.75,-49.36,;50.38,-52.34,;50.75,-53.81,;49.65,-54.89,;48.16,-54.47,;47.79,-52.98,;48.9,-51.91,)| InChI=1S/C27H42N4O/c1-4-28-18-27(32)29-17-22-19-31(26-8-6-5-7-25(22)26)24-13-15-30(16-14-24)23-11-9-21(10-12-23)20(2)3/h5-8,19-21,23-24,28H,4,9-18H2,1-3H3,(H,29,32) ADBGQUWNDQPXSG-UHFFFAOYSA-N 50514558 CHEMBL4519453 Nociceptin receptor Homo sapiens 16 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514558&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578342 440723140 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259117 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1ccc2ccccc12 |r,wD:6.9,3.2,(20.66,-19.76,;21.96,-18.93,;23.33,-19.65,;21.9,-17.39,;23.2,-16.56,;23.13,-15.02,;21.77,-14.31,;20.47,-15.14,;20.53,-16.67,;21.69,-12.77,;20.33,-12.06,;20.26,-10.53,;21.56,-9.69,;22.93,-10.4,;23,-11.94,;21.48,-8.16,;22.69,-7.2,;22.14,-5.76,;20.61,-5.84,;19.52,-4.75,;18.04,-5.14,;17.64,-6.63,;18.72,-7.71,;20.19,-7.32,)| InChI=1S/C22H32N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,11,16-18,20-21H,7-10,12-15H2,1-2H3 RUVSOGDMGUPNJT-UHFFFAOYSA-N 50514545 CHEMBL4435280 Mu-type opioid receptor Homo sapiens 376 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514545&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188443 440723127 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259118 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCCC2)c2ccccc12 |r,wD:6.9,3.2,(24.25,-47.25,;23.44,-45.94,;24.17,-44.58,;21.89,-45.98,;21.09,-44.68,;19.54,-44.72,;18.81,-46.07,;19.63,-47.39,;21.16,-47.34,;17.27,-46.13,;16.55,-47.48,;15.01,-47.53,;14.19,-46.23,;14.92,-44.87,;16.46,-44.82,;12.66,-46.28,;11.71,-45.07,;10.26,-45.59,;8.99,-44.74,;7.61,-45.41,;6.25,-44.7,;5.15,-45.76,;5.82,-47.14,;7.34,-46.93,;10.32,-47.13,;9.22,-48.2,;9.59,-49.7,;11.08,-50.11,;12.17,-49.04,;11.8,-47.56,)| InChI=1S/C27H41N3/c1-21(2)22-9-11-24(12-10-22)29-17-13-25(14-18-29)30-20-23(19-28-15-5-6-16-28)26-7-3-4-8-27(26)30/h3-4,7-8,20-22,24-25H,5-6,9-19H2,1-2H3 NGKDULCWDLWYAO-UHFFFAOYSA-N 50514557 CHEMBL4541337 Mu-type opioid receptor Homo sapiens 453 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514557&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578457 440723139 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259119 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(52.76,-21.76,;51.95,-20.45,;52.68,-19.09,;50.41,-20.49,;49.6,-19.19,;48.05,-19.23,;47.33,-20.58,;48.14,-21.89,;49.67,-21.85,;45.79,-20.64,;45.06,-21.99,;43.53,-22.04,;42.71,-20.74,;43.43,-19.38,;44.98,-19.33,;41.17,-20.79,;40.23,-19.58,;38.78,-20.1,;37.51,-19.25,;36.13,-19.92,;34.86,-19.07,;33.48,-19.74,;34.96,-17.54,;38.84,-21.64,;37.73,-22.71,;38.11,-24.2,;39.59,-24.62,;40.69,-23.55,;40.32,-22.07,)| InChI=1S/C24H36N4S/c1-17(2)18-7-9-20(10-8-18)27-13-11-21(12-14-27)28-16-19(15-26-24(25)29)22-5-3-4-6-23(22)28/h3-6,16-18,20-21H,7-15H2,1-2H3,(H3,25,26,29) BTZMBSYIWRQRBI-UHFFFAOYSA-N 50514539 CHEMBL4460695 Mu-type opioid receptor Homo sapiens 71 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514539&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563466 440723121 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259120 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)[C@@H](N)CCCNC(N)=N)c2ccccc12 |r,wU:22.24,wD:6.9,3.2,(63.55,-38.33,;62.74,-37.01,;63.48,-35.65,;61.19,-37.05,;60.38,-35.75,;58.84,-35.79,;58.11,-37.14,;58.92,-38.46,;60.46,-38.41,;56.57,-37.2,;55.84,-38.56,;54.3,-38.61,;53.48,-37.3,;54.2,-35.94,;55.75,-35.89,;51.94,-37.36,;51,-36.14,;49.55,-36.67,;48.27,-35.81,;46.89,-36.48,;45.62,-35.63,;45.72,-34.09,;44.24,-36.3,;44.13,-37.84,;42.96,-35.45,;41.58,-36.12,;40.3,-35.26,;38.92,-35.94,;37.65,-35.08,;36.27,-35.76,;37.75,-33.55,;49.61,-38.21,;48.5,-39.28,;48.87,-40.77,;50.36,-41.19,;51.46,-40.12,;51.09,-38.64,)| InChI=1S/C29H47N7O/c1-20(2)21-9-11-23(12-10-21)35-16-13-24(14-17-35)36-19-22(25-6-3-4-8-27(25)36)18-34-28(37)26(30)7-5-15-33-29(31)32/h3-4,6,8,19-21,23-24,26H,5,7,9-18,30H2,1-2H3,(H,34,37)(H4,31,32,33) WLQVWCBBPYAMOQ-UHFFFAOYSA-N 50514552 CHEMBL4594096 Mu-type opioid receptor Homo sapiens 857 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514552&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155569552 440723134 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259121 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN)c2ccccc12 |r,wD:6.9,3.2,(34,-19.87,;35.3,-19.05,;36.67,-19.77,;35.24,-17.51,;36.54,-16.68,;36.48,-15.14,;35.12,-14.43,;33.81,-15.26,;33.88,-16.79,;35.04,-12.89,;33.68,-12.18,;33.61,-10.65,;34.9,-9.81,;36.27,-10.52,;36.34,-12.06,;34.83,-8.28,;36.03,-7.32,;35.49,-5.88,;36.33,-4.59,;37.86,-4.68,;33.95,-5.95,;32.87,-4.86,;31.38,-5.25,;30.98,-6.74,;32.07,-7.83,;33.54,-7.44,)| InChI=1S/C23H35N3/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24)22-5-3-4-6-23(22)26/h3-6,16-18,20-21H,7-15,24H2,1-2H3 IPYIZXVSNKMLOX-UHFFFAOYSA-N 50514549 CHEMBL4548515 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514549&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563655 440723131 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259122 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCN)c2ccccc12 InChI=1S/C24H37N3/c1-18(2)19-7-9-21(10-8-19)26-15-12-22(13-16-26)27-17-20(11-14-25)23-5-3-4-6-24(23)27/h3-6,17-19,21-22H,7-16,25H2,1-2H3 OPIHQPUQFVMQAI-UHFFFAOYSA-N 50514550 CHEMBL4465668 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514550&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188462 440723132 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259123 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNCCO)c2ccccc12 |r,wD:6.9,3.2,(27.23,-22.87,;26.41,-21.55,;27.15,-20.19,;24.87,-21.59,;24.06,-20.29,;22.52,-20.33,;21.79,-21.68,;22.61,-23,;24.14,-22.95,;20.25,-21.74,;19.53,-23.1,;17.99,-23.15,;17.17,-21.84,;17.9,-20.48,;19.44,-20.43,;15.64,-21.9,;14.69,-20.68,;13.25,-21.21,;11.97,-20.35,;10.59,-21.03,;9.32,-20.17,;7.94,-20.84,;6.67,-19.99,;13.3,-22.75,;12.2,-23.82,;12.57,-25.31,;14.06,-25.72,;15.16,-24.65,;14.78,-23.18,)| InChI=1S/C25H39N3O/c1-19(2)20-7-9-22(10-8-20)27-14-11-23(12-15-27)28-18-21(17-26-13-16-29)24-5-3-4-6-25(24)28/h3-6,18-20,22-23,26,29H,7-17H2,1-2H3 MWMHYNCBTDRUCG-UHFFFAOYSA-N 50514544 CHEMBL4518220 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514544&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578518 440723126 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259124 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)[C@@H](N)CCCNC(N)=N)c2ccccc12 |r,wU:22.24,wD:6.9,3.2,(63.55,-38.33,;62.74,-37.01,;63.48,-35.65,;61.19,-37.05,;60.38,-35.75,;58.84,-35.79,;58.11,-37.14,;58.92,-38.46,;60.46,-38.41,;56.57,-37.2,;55.84,-38.56,;54.3,-38.61,;53.48,-37.3,;54.2,-35.94,;55.75,-35.89,;51.94,-37.36,;51,-36.14,;49.55,-36.67,;48.27,-35.81,;46.89,-36.48,;45.62,-35.63,;45.72,-34.09,;44.24,-36.3,;44.13,-37.84,;42.96,-35.45,;41.58,-36.12,;40.3,-35.26,;38.92,-35.94,;37.65,-35.08,;36.27,-35.76,;37.75,-33.55,;49.61,-38.21,;48.5,-39.28,;48.87,-40.77,;50.36,-41.19,;51.46,-40.12,;51.09,-38.64,)| InChI=1S/C29H47N7O/c1-20(2)21-9-11-23(12-10-21)35-16-13-24(14-17-35)36-19-22(25-6-3-4-8-27(25)36)18-34-28(37)26(30)7-5-15-33-29(31)32/h3-4,6,8,19-21,23-24,26H,5,7,9-18,30H2,1-2H3,(H,34,37)(H4,31,32,33) WLQVWCBBPYAMOQ-UHFFFAOYSA-N 50514552 CHEMBL4594096 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514552&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155569552 440723134 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259125 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)N1CCc2ccccc12 |r,wD:6.9,3.2,(8.81,-19.41,;10.12,-18.58,;11.48,-19.3,;10.05,-17.04,;11.35,-16.22,;11.29,-14.67,;9.93,-13.96,;8.62,-14.79,;8.69,-16.32,;9.85,-12.42,;8.49,-11.71,;8.42,-10.18,;9.71,-9.35,;11.08,-10.05,;11.15,-11.6,;9.64,-7.81,;10.84,-6.85,;10.3,-5.41,;8.76,-5.49,;7.68,-4.4,;6.19,-4.79,;5.79,-6.28,;6.88,-7.36,;8.35,-6.97,)| InChI=1S/C22H34N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,17-18,20-21H,7-16H2,1-2H3 FALYKCYWERAVPH-UHFFFAOYSA-N 50514548 CHEMBL4570328 Kappa-type opioid receptor Homo sapiens 562 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514548&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188459 440723130 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259126 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCN)c2ccccc12 InChI=1S/C24H37N3/c1-18(2)19-7-9-21(10-8-19)26-15-12-22(13-16-26)27-17-20(11-14-25)23-5-3-4-6-24(23)27/h3-6,17-19,21-22H,7-16,25H2,1-2H3 OPIHQPUQFVMQAI-UHFFFAOYSA-N 50514550 CHEMBL4465668 Kappa-type opioid receptor Homo sapiens 2750 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514550&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188462 440723132 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259127 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC[C@@H](O)C2)c2ccccc12 |r,wD:6.9,3.2,22.24,(23.74,-8.52,;22.92,-7.21,;23.66,-5.85,;21.38,-7.25,;20.57,-5.95,;19.03,-5.99,;18.3,-7.34,;19.12,-8.66,;20.65,-8.61,;16.76,-7.4,;16.04,-8.75,;14.5,-8.81,;13.68,-7.5,;14.4,-6.14,;15.95,-6.09,;12.15,-7.56,;11.2,-6.34,;9.75,-6.87,;8.48,-6.01,;7.1,-6.68,;5.74,-5.97,;4.64,-7.04,;5.31,-8.41,;4.59,-9.77,;6.83,-8.2,;9.81,-8.41,;8.71,-9.47,;9.08,-10.97,;10.56,-11.38,;11.66,-10.31,;11.29,-8.84,)| InChI=1S/C27H41N3O/c1-20(2)21-7-9-23(10-8-21)29-15-11-24(12-16-29)30-18-22(17-28-14-13-25(31)19-28)26-5-3-4-6-27(26)30/h3-6,18,20-21,23-25,31H,7-17,19H2,1-2H3 UVJCSVMAXSVVJZ-UHFFFAOYSA-N 50514541 CHEMBL4473045 Kappa-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514541&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578456 440723123 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259128 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(27.01,-36.98,;26.19,-35.66,;26.93,-34.3,;24.65,-35.71,;23.85,-34.4,;22.3,-34.44,;21.57,-35.79,;22.39,-37.11,;23.92,-37.06,;20.03,-35.85,;19.31,-37.21,;17.77,-37.26,;16.95,-35.95,;17.67,-34.59,;19.22,-34.54,;15.42,-36.01,;14.47,-34.79,;13.02,-35.32,;11.75,-34.46,;10.37,-35.14,;9.1,-34.28,;7.72,-34.96,;6.45,-34.1,;5.07,-34.77,;6.55,-32.57,;13.08,-36.86,;11.98,-37.93,;12.35,-39.42,;13.83,-39.84,;14.93,-38.76,;14.56,-37.29,)| InChI=1S/C26H40N4S/c1-19(2)20-9-11-22(12-10-20)29-16-13-23(14-17-29)30-18-21(6-5-15-28-26(27)31)24-7-3-4-8-25(24)30/h3-4,7-8,18-20,22-23H,5-6,9-17H2,1-2H3,(H3,27,28,31) NBGHZUOQLIHUSD-UHFFFAOYSA-N 50514556 CHEMBL4591048 Kappa-type opioid receptor Homo sapiens 830 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514556&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563699 440723138 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259129 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)N1CCc2ccccc12 |r,wD:6.9,3.2,(8.81,-19.41,;10.12,-18.58,;11.48,-19.3,;10.05,-17.04,;11.35,-16.22,;11.29,-14.67,;9.93,-13.96,;8.62,-14.79,;8.69,-16.32,;9.85,-12.42,;8.49,-11.71,;8.42,-10.18,;9.71,-9.35,;11.08,-10.05,;11.15,-11.6,;9.64,-7.81,;10.84,-6.85,;10.3,-5.41,;8.76,-5.49,;7.68,-4.4,;6.19,-4.79,;5.79,-6.28,;6.88,-7.36,;8.35,-6.97,)| InChI=1S/C22H34N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,17-18,20-21H,7-16H2,1-2H3 FALYKCYWERAVPH-UHFFFAOYSA-N 50514548 CHEMBL4570328 Nociceptin receptor Homo sapiens 55 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514548&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188459 440723130 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259130 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CO)c2ccccc12 |r,wD:6.9,3.2,(63.96,-12.85,;63.15,-11.53,;63.89,-10.17,;61.61,-11.57,;60.8,-10.27,;59.26,-10.31,;58.53,-11.66,;59.34,-12.98,;60.88,-12.93,;56.99,-11.72,;56.27,-13.07,;54.73,-13.13,;53.91,-11.82,;54.63,-10.46,;56.18,-10.41,;52.38,-11.88,;51.43,-10.66,;49.98,-11.19,;48.71,-10.33,;48.82,-8.8,;50.04,-12.73,;48.94,-13.79,;49.31,-15.29,;50.79,-15.7,;51.89,-14.63,;51.52,-13.16,)| InChI=1S/C23H34N2O/c1-17(2)18-7-9-20(10-8-18)24-13-11-21(12-14-24)25-15-19(16-26)22-5-3-4-6-23(22)25/h3-6,15,17-18,20-21,26H,7-14,16H2,1-2H3 JDXUKGDQAXGTDS-UHFFFAOYSA-N 50514540 CHEMBL4439997 Nociceptin receptor Homo sapiens 117 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514540&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563650 440723122 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259131 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN(C)C)c2ccccc12 |r,wD:6.9,3.2,(22.93,-34.28,;22.12,-32.96,;22.85,-31.6,;20.58,-33,;19.77,-31.7,;18.22,-31.74,;17.5,-33.09,;18.31,-34.41,;19.85,-34.36,;15.96,-33.15,;15.23,-34.51,;13.7,-34.56,;12.88,-33.25,;13.6,-31.89,;15.15,-31.84,;11.35,-33.31,;10.4,-32.09,;8.95,-32.62,;7.68,-31.76,;7.78,-30.23,;6.51,-29.38,;9.16,-29.56,;9.01,-34.16,;7.91,-35.23,;8.28,-36.72,;9.76,-37.13,;10.86,-36.06,;10.49,-34.59,)| InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-15-13-23(14-16-27)28-18-21(17-26(3)4)24-7-5-6-8-25(24)28/h5-8,18-20,22-23H,9-17H2,1-4H3 WVGUPYZLPGESLO-UHFFFAOYSA-N 50514538 CHEMBL4457077 Mu-type opioid receptor Homo sapiens 504 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514538&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563691 440723120 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259132 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1ccc2ccccc12 |r,wD:6.9,3.2,(20.66,-19.76,;21.96,-18.93,;23.33,-19.65,;21.9,-17.39,;23.2,-16.56,;23.13,-15.02,;21.77,-14.31,;20.47,-15.14,;20.53,-16.67,;21.69,-12.77,;20.33,-12.06,;20.26,-10.53,;21.56,-9.69,;22.93,-10.4,;23,-11.94,;21.48,-8.16,;22.69,-7.2,;22.14,-5.76,;20.61,-5.84,;19.52,-4.75,;18.04,-5.14,;17.64,-6.63,;18.72,-7.71,;20.19,-7.32,)| InChI=1S/C22H32N2/c1-17(2)18-7-9-20(10-8-18)23-14-12-21(13-15-23)24-16-11-19-5-3-4-6-22(19)24/h3-6,11,16-18,20-21H,7-10,12-15H2,1-2H3 RUVSOGDMGUPNJT-UHFFFAOYSA-N 50514545 CHEMBL4435280 Kappa-type opioid receptor Homo sapiens 1594 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514545&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188443 440723127 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259133 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCCC2)c2ccccc12 |r,wD:6.9,3.2,(24.25,-47.25,;23.44,-45.94,;24.17,-44.58,;21.89,-45.98,;21.09,-44.68,;19.54,-44.72,;18.81,-46.07,;19.63,-47.39,;21.16,-47.34,;17.27,-46.13,;16.55,-47.48,;15.01,-47.53,;14.19,-46.23,;14.92,-44.87,;16.46,-44.82,;12.66,-46.28,;11.71,-45.07,;10.26,-45.59,;8.99,-44.74,;7.61,-45.41,;6.25,-44.7,;5.15,-45.76,;5.82,-47.14,;7.34,-46.93,;10.32,-47.13,;9.22,-48.2,;9.59,-49.7,;11.08,-50.11,;12.17,-49.04,;11.8,-47.56,)| InChI=1S/C27H41N3/c1-21(2)22-9-11-24(12-10-22)29-17-13-25(14-18-29)30-20-23(19-28-15-5-6-16-28)26-7-3-4-8-27(26)30/h3-4,7-8,20-22,24-25H,5-6,9-19H2,1-2H3 NGKDULCWDLWYAO-UHFFFAOYSA-N 50514557 CHEMBL4541337 Nociceptin receptor Homo sapiens 1.5 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514557&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578457 440723139 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259134 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(27.01,-36.98,;26.19,-35.66,;26.93,-34.3,;24.65,-35.71,;23.85,-34.4,;22.3,-34.44,;21.57,-35.79,;22.39,-37.11,;23.92,-37.06,;20.03,-35.85,;19.31,-37.21,;17.77,-37.26,;16.95,-35.95,;17.67,-34.59,;19.22,-34.54,;15.42,-36.01,;14.47,-34.79,;13.02,-35.32,;11.75,-34.46,;10.37,-35.14,;9.1,-34.28,;7.72,-34.96,;6.45,-34.1,;5.07,-34.77,;6.55,-32.57,;13.08,-36.86,;11.98,-37.93,;12.35,-39.42,;13.83,-39.84,;14.93,-38.76,;14.56,-37.29,)| InChI=1S/C26H40N4S/c1-19(2)20-9-11-22(12-10-20)29-16-13-23(14-17-29)30-18-21(6-5-15-28-26(27)31)24-7-3-4-8-25(24)30/h3-4,7-8,18-20,22-23H,5-6,9-17H2,1-2H3,(H3,27,28,31) NBGHZUOQLIHUSD-UHFFFAOYSA-N 50514556 CHEMBL4591048 Nociceptin receptor Homo sapiens 32 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514556&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563699 440723138 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259135 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN)c2ccccc12 |r,wD:6.9,3.2,(34,-19.87,;35.3,-19.05,;36.67,-19.77,;35.24,-17.51,;36.54,-16.68,;36.48,-15.14,;35.12,-14.43,;33.81,-15.26,;33.88,-16.79,;35.04,-12.89,;33.68,-12.18,;33.61,-10.65,;34.9,-9.81,;36.27,-10.52,;36.34,-12.06,;34.83,-8.28,;36.03,-7.32,;35.49,-5.88,;36.33,-4.59,;37.86,-4.68,;33.95,-5.95,;32.87,-4.86,;31.38,-5.25,;30.98,-6.74,;32.07,-7.83,;33.54,-7.44,)| InChI=1S/C23H35N3/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24)22-5-3-4-6-23(22)26/h3-6,16-18,20-21H,7-15,24H2,1-2H3 IPYIZXVSNKMLOX-UHFFFAOYSA-N 50514549 CHEMBL4548515 Mu-type opioid receptor Homo sapiens 2.4 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514549&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563655 440723131 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259136 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(C(N)=O)c2ccccc12 |r,wD:6.9,3.2,(24.31,-8.5,;23.5,-7.18,;24.23,-5.83,;21.96,-7.23,;21.15,-5.92,;19.6,-5.96,;18.88,-7.32,;19.69,-8.63,;21.22,-8.59,;17.34,-7.38,;16.61,-8.73,;15.08,-8.78,;14.26,-7.48,;14.98,-6.11,;16.53,-6.06,;12.72,-7.53,;11.78,-6.31,;10.33,-6.84,;9.06,-5.98,;7.68,-6.66,;9.16,-4.45,;10.39,-8.38,;9.29,-9.45,;9.66,-10.94,;11.14,-11.36,;12.24,-10.29,;11.87,-8.81,)| InChI=1S/C23H33N3O/c1-16(2)17-7-9-18(10-8-17)25-13-11-19(12-14-25)26-15-21(23(24)27)20-5-3-4-6-22(20)26/h3-6,15-19H,7-14H2,1-2H3,(H2,24,27) OLKROLWNEXOWRE-UHFFFAOYSA-N 50514542 CHEMBL4473383 Mu-type opioid receptor Homo sapiens 453 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514542&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563695 440723124 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259137 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCN)c2ccccc12 InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-16-13-23(14-17-27)28-18-21(6-5-15-26)24-7-3-4-8-25(24)28/h3-4,7-8,18-20,22-23H,5-6,9-17,26H2,1-2H3 SJRTYDYZXKADCH-UHFFFAOYSA-N 50514547 CHEMBL4451073 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514547&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563704 440723129 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259138 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(27.01,-36.98,;26.19,-35.66,;26.93,-34.3,;24.65,-35.71,;23.85,-34.4,;22.3,-34.44,;21.57,-35.79,;22.39,-37.11,;23.92,-37.06,;20.03,-35.85,;19.31,-37.21,;17.77,-37.26,;16.95,-35.95,;17.67,-34.59,;19.22,-34.54,;15.42,-36.01,;14.47,-34.79,;13.02,-35.32,;11.75,-34.46,;10.37,-35.14,;9.1,-34.28,;7.72,-34.96,;6.45,-34.1,;5.07,-34.77,;6.55,-32.57,;13.08,-36.86,;11.98,-37.93,;12.35,-39.42,;13.83,-39.84,;14.93,-38.76,;14.56,-37.29,)| InChI=1S/C26H40N4S/c1-19(2)20-9-11-22(12-10-20)29-16-13-23(14-17-29)30-18-21(6-5-15-28-26(27)31)24-7-3-4-8-25(24)30/h3-4,7-8,18-20,22-23H,5-6,9-17H2,1-2H3,(H3,27,28,31) NBGHZUOQLIHUSD-UHFFFAOYSA-N 50514556 CHEMBL4591048 Delta-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514556&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563699 440723138 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259139 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC(O)C2)c2ccccc12 |r,wD:6.9,3.2,(51.84,-7.48,;51.03,-6.16,;51.76,-4.81,;49.48,-6.21,;48.68,-4.9,;47.13,-4.94,;46.4,-6.3,;47.22,-7.61,;48.75,-7.57,;44.87,-6.36,;44.14,-7.71,;42.6,-7.76,;41.78,-6.46,;42.51,-5.09,;44.05,-5.04,;40.25,-6.51,;39.3,-5.29,;37.86,-5.82,;36.58,-4.96,;35.2,-5.64,;33.75,-5.14,;33.25,-6.59,;31.87,-7.26,;34.7,-7.09,;37.92,-7.36,;36.81,-8.43,;37.18,-9.92,;38.67,-10.34,;39.77,-9.27,;39.39,-7.79,)| InChI=1S/C26H39N3O/c1-19(2)20-7-9-22(10-8-20)28-13-11-23(12-14-28)29-16-21(15-27-17-24(30)18-27)25-5-3-4-6-26(25)29/h3-6,16,19-20,22-24,30H,7-15,17-18H2,1-2H3 LCHNDEARQJNFQA-UHFFFAOYSA-N 50514554 CHEMBL4556227 Kappa-type opioid receptor Homo sapiens >10000 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514554&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563496 440723136 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259140 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(C(N)=O)c2ccccc12 |r,wD:6.9,3.2,(24.31,-8.5,;23.5,-7.18,;24.23,-5.83,;21.96,-7.23,;21.15,-5.92,;19.6,-5.96,;18.88,-7.32,;19.69,-8.63,;21.22,-8.59,;17.34,-7.38,;16.61,-8.73,;15.08,-8.78,;14.26,-7.48,;14.98,-6.11,;16.53,-6.06,;12.72,-7.53,;11.78,-6.31,;10.33,-6.84,;9.06,-5.98,;7.68,-6.66,;9.16,-4.45,;10.39,-8.38,;9.29,-9.45,;9.66,-10.94,;11.14,-11.36,;12.24,-10.29,;11.87,-8.81,)| InChI=1S/C23H33N3O/c1-16(2)17-7-9-18(10-8-17)25-13-11-19(12-14-25)26-15-21(23(24)27)20-5-3-4-6-22(20)26/h3-6,15-19H,7-14H2,1-2H3,(H2,24,27) OLKROLWNEXOWRE-UHFFFAOYSA-N 50514542 CHEMBL4473383 Kappa-type opioid receptor Homo sapiens 446 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514542&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563695 440723124 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259141 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCN)c2ccccc12 InChI=1S/C24H37N3/c1-18(2)19-7-9-21(10-8-19)26-15-12-22(13-16-26)27-17-20(11-14-25)23-5-3-4-6-24(23)27/h3-6,17-19,21-22H,7-16,25H2,1-2H3 OPIHQPUQFVMQAI-UHFFFAOYSA-N 50514550 CHEMBL4465668 Nociceptin receptor Homo sapiens 139 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514550&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 129188462 440723132 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259142 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC(O)C2)c2ccccc12 |r,wD:6.9,3.2,(51.84,-7.48,;51.03,-6.16,;51.76,-4.81,;49.48,-6.21,;48.68,-4.9,;47.13,-4.94,;46.4,-6.3,;47.22,-7.61,;48.75,-7.57,;44.87,-6.36,;44.14,-7.71,;42.6,-7.76,;41.78,-6.46,;42.51,-5.09,;44.05,-5.04,;40.25,-6.51,;39.3,-5.29,;37.86,-5.82,;36.58,-4.96,;35.2,-5.64,;33.75,-5.14,;33.25,-6.59,;31.87,-7.26,;34.7,-7.09,;37.92,-7.36,;36.81,-8.43,;37.18,-9.92,;38.67,-10.34,;39.77,-9.27,;39.39,-7.79,)| InChI=1S/C26H39N3O/c1-19(2)20-7-9-22(10-8-20)28-13-11-23(12-14-28)29-16-21(15-27-17-24(30)18-27)25-5-3-4-6-26(25)29/h3-6,16,19-20,22-24,30H,7-15,17-18H2,1-2H3 LCHNDEARQJNFQA-UHFFFAOYSA-N 50514554 CHEMBL4556227 Nociceptin receptor Homo sapiens 24 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514554&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563496 440723136 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259143 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)CCCCCN)c2ccccc12 |r,wD:6.9,3.2,(30.71,-51.51,;29.9,-50.19,;30.64,-48.83,;28.36,-50.23,;27.55,-48.92,;26,-48.97,;25.27,-50.32,;26.09,-51.64,;27.62,-51.59,;23.73,-50.38,;23,-51.74,;21.47,-51.79,;20.64,-50.48,;21.37,-49.12,;22.92,-49.07,;19.11,-50.54,;18.16,-49.32,;16.71,-49.84,;15.44,-48.99,;14.06,-49.66,;12.78,-48.81,;12.89,-47.27,;11.4,-49.48,;10.13,-48.62,;8.75,-49.3,;7.47,-48.44,;6.09,-49.12,;4.82,-48.26,;16.77,-51.39,;15.66,-52.46,;16.04,-53.95,;17.52,-54.37,;18.62,-53.29,;18.25,-51.82,)| InChI=1S/C29H46N4O/c1-22(2)23-11-13-25(14-12-23)32-18-15-26(16-19-32)33-21-24(27-8-5-6-9-28(27)33)20-31-29(34)10-4-3-7-17-30/h5-6,8-9,21-23,25-26H,3-4,7,10-20,30H2,1-2H3,(H,31,34) ZUGCJUUUBNUVGL-UHFFFAOYSA-N 50514546 CHEMBL4521436 Mu-type opioid receptor Homo sapiens 949 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514546&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 155542684 440723128 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259144 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(O)CC2)c2ccccc12 |r,wD:6.9,3.2,(75.58,-45.79,;74.76,-44.48,;75.5,-43.12,;73.22,-44.52,;72.41,-43.21,;70.87,-43.26,;70.14,-44.61,;70.95,-45.93,;72.49,-45.88,;68.6,-44.67,;67.87,-46.02,;66.34,-46.07,;65.52,-44.77,;66.24,-43.41,;67.79,-43.36,;63.98,-44.82,;63.04,-43.61,;61.59,-44.13,;60.32,-43.28,;58.94,-43.95,;57.67,-43.09,;56.29,-43.76,;56.18,-45.29,;54.8,-45.96,;57.45,-46.15,;58.84,-45.48,;61.65,-45.67,;60.54,-46.74,;60.91,-48.24,;62.4,-48.65,;63.5,-47.58,;63.13,-46.1,)| InChI=1S/C28H43N3O/c1-21(2)22-7-9-24(10-8-22)30-17-11-25(12-18-30)31-20-23(27-5-3-4-6-28(27)31)19-29-15-13-26(32)14-16-29/h3-6,20-22,24-26,32H,7-19H2,1-2H3 PCXCVPKTSPZHJW-UHFFFAOYSA-N 50514551 CHEMBL4550088 Delta-type opioid receptor Homo sapiens 6028 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2100&target=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514551&enzyme=Delta-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578506 440723133 1 MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA 8Y71,4RWD,4RWA Delta-type opioid receptor OPRD_HUMAN P41143 B5B0B8 51259145 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCNC(N)=S)c2ccccc12 |r,wD:6.9,3.2,(77.5,-21.25,;76.69,-19.93,;77.42,-18.58,;75.15,-19.98,;74.34,-18.67,;72.79,-18.71,;72.06,-20.07,;72.88,-21.38,;74.41,-21.34,;70.53,-20.13,;69.8,-21.48,;68.27,-21.53,;67.45,-20.23,;68.17,-18.86,;69.71,-18.81,;65.91,-20.28,;64.97,-19.06,;63.52,-19.59,;62.24,-18.73,;60.87,-19.41,;59.59,-18.55,;58.21,-19.23,;56.94,-18.37,;58.11,-20.76,;63.58,-21.13,;62.47,-22.2,;62.84,-23.69,;64.33,-24.11,;65.43,-23.04,;65.06,-21.56,)| InChI=1S/C25H38N4S/c1-18(2)19-7-9-21(10-8-19)28-15-12-22(13-16-28)29-17-20(11-14-27-25(26)30)23-5-3-4-6-24(23)29/h3-6,17-19,21-22H,7-16H2,1-2H3,(H3,26,27,30) SDNMVMVANFPUFO-UHFFFAOYSA-N 50514555 CHEMBL4467156 Kappa-type opioid receptor Homo sapiens 81 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514555&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563698 440723137 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4 51259146 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CCC(O)CC2)c2ccccc12 |r,wD:6.9,3.2,(75.58,-45.79,;74.76,-44.48,;75.5,-43.12,;73.22,-44.52,;72.41,-43.21,;70.87,-43.26,;70.14,-44.61,;70.95,-45.93,;72.49,-45.88,;68.6,-44.67,;67.87,-46.02,;66.34,-46.07,;65.52,-44.77,;66.24,-43.41,;67.79,-43.36,;63.98,-44.82,;63.04,-43.61,;61.59,-44.13,;60.32,-43.28,;58.94,-43.95,;57.67,-43.09,;56.29,-43.76,;56.18,-45.29,;54.8,-45.96,;57.45,-46.15,;58.84,-45.48,;61.65,-45.67,;60.54,-46.74,;60.91,-48.24,;62.4,-48.65,;63.5,-47.58,;63.13,-46.1,)| InChI=1S/C28H43N3O/c1-21(2)22-7-9-24(10-8-22)30-17-11-25(12-18-30)31-20-23(27-5-3-4-6-28(27)31)19-29-15-13-26(32)14-16-29/h3-6,20-22,24-26,32H,7-19H2,1-2H3 PCXCVPKTSPZHJW-UHFFFAOYSA-N 50514551 CHEMBL4550088 Nociceptin receptor Homo sapiens 446 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514551&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578506 440723133 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259147 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC(O)C2)c2ccccc12 |r,wD:6.9,3.2,(51.84,-7.48,;51.03,-6.16,;51.76,-4.81,;49.48,-6.21,;48.68,-4.9,;47.13,-4.94,;46.4,-6.3,;47.22,-7.61,;48.75,-7.57,;44.87,-6.36,;44.14,-7.71,;42.6,-7.76,;41.78,-6.46,;42.51,-5.09,;44.05,-5.04,;40.25,-6.51,;39.3,-5.29,;37.86,-5.82,;36.58,-4.96,;35.2,-5.64,;33.75,-5.14,;33.25,-6.59,;31.87,-7.26,;34.7,-7.09,;37.92,-7.36,;36.81,-8.43,;37.18,-9.92,;38.67,-10.34,;39.77,-9.27,;39.39,-7.79,)| InChI=1S/C26H39N3O/c1-19(2)20-7-9-22(10-8-20)28-13-11-23(12-14-28)29-16-21(15-27-17-24(30)18-27)25-5-3-4-6-26(25)29/h3-6,16,19-20,22-24,30H,7-15,17-18H2,1-2H3 LCHNDEARQJNFQA-UHFFFAOYSA-N 50514554 CHEMBL4556227 Nociceptin receptor Homo sapiens 1559 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514554&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563496 440723136 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259148 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CNC(=O)CCCCCN)c2ccccc12 |r,wD:6.9,3.2,(30.71,-51.51,;29.9,-50.19,;30.64,-48.83,;28.36,-50.23,;27.55,-48.92,;26,-48.97,;25.27,-50.32,;26.09,-51.64,;27.62,-51.59,;23.73,-50.38,;23,-51.74,;21.47,-51.79,;20.64,-50.48,;21.37,-49.12,;22.92,-49.07,;19.11,-50.54,;18.16,-49.32,;16.71,-49.84,;15.44,-48.99,;14.06,-49.66,;12.78,-48.81,;12.89,-47.27,;11.4,-49.48,;10.13,-48.62,;8.75,-49.3,;7.47,-48.44,;6.09,-49.12,;4.82,-48.26,;16.77,-51.39,;15.66,-52.46,;16.04,-53.95,;17.52,-54.37,;18.62,-53.29,;18.25,-51.82,)| InChI=1S/C29H46N4O/c1-22(2)23-11-13-25(14-12-23)32-18-15-26(16-19-32)33-21-24(27-8-5-6-9-28(27)33)20-31-29(34)10-4-3-7-17-30/h5-6,8-9,21-23,25-26H,3-4,7,10-20,30H2,1-2H3,(H,31,34) ZUGCJUUUBNUVGL-UHFFFAOYSA-N 50514546 CHEMBL4521436 Nociceptin receptor Homo sapiens 464 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2210&target=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514546&enzyme=Nociceptin+receptor&column=ki&startPg=0&Increment=50&submit=Search 155542684 440723128 1 MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA 8F7X Nociceptin receptor OPRX_HUMAN P41146 Q8TD34 Q8WYH9 Q9H4K4 51259149 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CCCN)c2ccccc12 InChI=1S/C25H39N3/c1-19(2)20-9-11-22(12-10-20)27-16-13-23(14-17-27)28-18-21(6-5-15-26)24-7-3-4-8-25(24)28/h3-4,7-8,18-20,22-23H,5-6,9-17,26H2,1-2H3 SJRTYDYZXKADCH-UHFFFAOYSA-N 50514547 CHEMBL4451073 Mu-type opioid receptor Homo sapiens 1764 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514547&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563704 440723129 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259150 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN2CC[C@@H](O)C2)c2ccccc12 |r,wD:6.9,3.2,22.24,(23.74,-8.52,;22.92,-7.21,;23.66,-5.85,;21.38,-7.25,;20.57,-5.95,;19.03,-5.99,;18.3,-7.34,;19.12,-8.66,;20.65,-8.61,;16.76,-7.4,;16.04,-8.75,;14.5,-8.81,;13.68,-7.5,;14.4,-6.14,;15.95,-6.09,;12.15,-7.56,;11.2,-6.34,;9.75,-6.87,;8.48,-6.01,;7.1,-6.68,;5.74,-5.97,;4.64,-7.04,;5.31,-8.41,;4.59,-9.77,;6.83,-8.2,;9.81,-8.41,;8.71,-9.47,;9.08,-10.97,;10.56,-11.38,;11.66,-10.31,;11.29,-8.84,)| InChI=1S/C27H41N3O/c1-20(2)21-7-9-23(10-8-21)29-15-11-24(12-16-29)30-18-22(17-28-14-13-25(31)19-28)26-5-3-4-6-27(26)30/h3-6,18,20-21,23-25,31H,7-17,19H2,1-2H3 UVJCSVMAXSVVJZ-UHFFFAOYSA-N 50514541 CHEMBL4473045 Mu-type opioid receptor Homo sapiens 306 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2213&target=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514541&enzyme=Mu-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134578456 440723123 1 MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP 9PY4,9PY3,9PY2,9PXY,9PXX,9PXW,9PXV,8EFQ,8EFO,8EFL,8EF6,8EF5,4DKL Mu-type opioid receptor OPRM_HUMAN P35372 B0FXJ1 B2R9S7 B8Q1L7 B8Q1L8 B8Q1L9 E7EWZ3 G8XRH6 G8XRH8 Q12930 Q4VWM1 Q4VWM2 Q4VWM3 Q4VWM4 Q4VWM6 Q4VWX6 Q5TDA1 Q6UPP1 Q6UQ80 Q7Z2D8 Q86V80 Q8IWW3 Q8IWW4 Q9UCZ4 Q9UN57 51259151 CC(C)[C@H]1CC[C@H](CC1)N1CCC(CC1)n1cc(CN)c2ccccc12 |r,wD:6.9,3.2,(34,-19.87,;35.3,-19.05,;36.67,-19.77,;35.24,-17.51,;36.54,-16.68,;36.48,-15.14,;35.12,-14.43,;33.81,-15.26,;33.88,-16.79,;35.04,-12.89,;33.68,-12.18,;33.61,-10.65,;34.9,-9.81,;36.27,-10.52,;36.34,-12.06,;34.83,-8.28,;36.03,-7.32,;35.49,-5.88,;36.33,-4.59,;37.86,-4.68,;33.95,-5.95,;32.87,-4.86,;31.38,-5.25,;30.98,-6.74,;32.07,-7.83,;33.54,-7.44,)| InChI=1S/C23H35N3/c1-17(2)18-7-9-20(10-8-18)25-13-11-21(12-14-25)26-16-19(15-24)22-5-3-4-6-23(22)26/h3-6,16-18,20-21H,7-15,24H2,1-2H3 IPYIZXVSNKMLOX-UHFFFAOYSA-N 50514549 CHEMBL4548515 Kappa-type opioid receptor Homo sapiens 172 ChEMBL 10.1021/acs.jmedchem.9b02134 10.7270/Q2CJ8HV0 31951130 Kamakolanu, UG; Meyer, ME; Yasuda, D; Polgar, WE; Marti, M; Mercatelli, D; Pisanò, CA; Brugnoli, A; Morari, M; Zaveri, NT 3/12/2020 2/21/2021 Astraea Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50514549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2212&target=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50514549&enzyme=Kappa-type+opioid+receptor&column=ki&startPg=0&Increment=50&submit=Search 134563655 440723131 1 MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV 9D61,8VVG,8VVF,8VVE,9L60,8F7W,8FEG,7YIT,4DJH Kappa-type opioid receptor OPRK_HUMAN P41145 E5RHC9 Q499G4